WO2001022934A2 - Delivery of small doses of ingestible treatments - Google Patents

Delivery of small doses of ingestible treatments Download PDF

Info

Publication number
WO2001022934A2
WO2001022934A2 PCT/US2000/025882 US0025882W WO0122934A2 WO 2001022934 A2 WO2001022934 A2 WO 2001022934A2 US 0025882 W US0025882 W US 0025882W WO 0122934 A2 WO0122934 A2 WO 0122934A2
Authority
WO
WIPO (PCT)
Prior art keywords
recited
bioactive substance
delivery vehicle
animal
human
Prior art date
Application number
PCT/US2000/025882
Other languages
French (fr)
Other versions
WO2001022934A3 (en
Inventor
Quing Non Yng-Wong
Original Assignee
Yng Wong Quing Non
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yng Wong Quing Non filed Critical Yng Wong Quing Non
Priority to AU77068/00A priority Critical patent/AU7706800A/en
Publication of WO2001022934A2 publication Critical patent/WO2001022934A2/en
Publication of WO2001022934A3 publication Critical patent/WO2001022934A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254Acanthopanax or Eleutherococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/79Schisandraceae (Schisandra family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Definitions

  • the delivery system involves a vehicle that may comprise a wafer that may be used in the practice of the method a method of making an approximately one hundred thousand-fold attenuation depending on the particular medicinal or food supplement, and a method of introducing the vehicle containing the attenuation
  • the active chemical constituents of an herbal formula are generally present in the range of about 0 1 % (for most herbs) - 80% (for certain herbs with a very high molecular weight bioactive substance) of the total weight of the herbal extracts
  • the range of attenuation used in the preparation of the medicinal or food supplement ranges from between about 10 3 to 10 7
  • the amount of diluted material applied to the delivery vehicle is 5-10 microliters
  • this invention delivers from 8 x 10 5 to 5 x 10 13 grams of an active substance or substances to a human or other mammal in order to get
  • the structures reflect the electronic and geometric properties of the original bioactive molecule
  • Such ice-like structures form under enormously high electrostatic pressures that are generally neglected when considering the hydratio ⁇ of molecules and ions in aqueous solution.
  • Such stable water clusters possess magnified electric dipole moments and contain considerable crystal lattice energy which may be imparted to cell membrane receptor molecules upon interaction
  • the tongue is perhaps the first sensory organ that comes in contact with a dose of medicine
  • Modern pharmacology with its emphasis on delivery of bio-active substances through the bloodstream, has neglected the first therapeutic agency in the human body
  • Stimulation of these gustatory receptors is known to cause either a change in ion flux or the activation of a G-protein coupled response in the membrane of the taste cell, depending on the stimuli This stimulation initiates signal transduction mechanisms which result in the propagation of nerve impulses along primary afferent nerve fibers
  • Glutamate synapses are excitatory synapses that function via balancing of the excitatory action of the glutamate with the inhibitory action of gamma ammo butyric acid (GABA)
  • the signal that reaches the rNTS at the glutamate/GABA synapse is a complex summation of the signal seen when the two areas are stimulated individually
  • the NTS there are also neurons containing adrenergic and mu-opioid synapses
  • these types of neurons are involved in sugar utilization and feeding behavior, respectively, they are expected to be responsive to gustatory cues given in nanodose form
  • the limbic area which includes the amygdala and the hippocampus is known to be involved in depression, anxiety, emotions some types of learned behaviors, motivation, sexual and hedonistic behavior, feeding behavior, and fear
  • the neural information coded in the rNTS is thought to be relayed to an area of the insular cortex sometimes referred to as the gustatory cortex, largely by glutamate/GABA coding In fact, the induction of magnetic fields in response to gustatory stimuli have been detected in this region of the brain
  • the active chemical constituents of nanodose preparations have been diluted so that the quantity of bioactive molecules is on the order of about 8 micrograms - 0 5 picograms This is the approximate amount of the active substance that is applied to the caroohydrate or non-carbohydrate delivery vehicle (wafer, lactose pellet gelatin capsule) etc
  • the caroohydrate or non-carbohydrate delivery vehicle wafer, lactose pellet gelatin capsule
  • the only known substances active at this level in whole animal bloodstreams are extremely active neurotoxins, which are not in the class of inherently beneficial bioactive substances according to the invention
  • substantially the only delivery mechanism for treatments according to the invention is influencing the gustatory (and possibly olfactory) receptors, which neurostimulate the brain so as to effect a positive physical manifestation in a human or animal (typically mammal) patient That is the bloodstream is not involved in the basic delivery mechanism according to the invention but rather there is a trigger effect provided by, relatively speaking, only a few molecules While in some circumstances treatment according to the invention may be followed up with more conventional treatments involving delivery through the bloodstream or nasal passageways, for many bioactive materials only treatment according to the invention need be employed
  • Treatment according to the invention has numerous advantages over conventional pharmacological or focd supplement treatments These advantages include much reduced expense (highly significant for some materials now costing on the order of S25-$100, or more per dose), wider-spread effective utilization of rare bioactive substances, speed of action, and significant reduction (if not elimination) of adverse side effects, while still obtaining at least substantially the same positive effectiveness of treatment
  • the present invention there is provided a method of treating a human or animal by neurostimulating the human's or animal's brain to effect a positive physical manifestation by substantially solely influencing the human's or animal's gustatory or gust
  • the method as described above may be practiced so as to influence substantially only the gustatory receptors, by bringing the gustatory receptors into contact with only between about 8 micrograms and 0 5 picograms (or about 5-10 microliters of about 6 7 x 10 8 to 2 5 x 10 1 ° molar solution) of a bioactive substance or any other narrower range within that broad range including (but not limited to) 1 x 10 9 to 1 x 10 11 grams
  • the bioactive substance may be applied on or incorporated with a delivery vehicle that is adapted to be dissolved in a human's or animal's mouth and brought into contact with the gustatory receptors on tne tongue and other portions of the mouth perhaps also with olfactory receptor involvement
  • the bioactive substance may be produced by dilutions using conventional Chinese standards and formulations for dispensing herbal supplements, and then may be sprayed on or incorporated in a wafer, lozenge capsule or other conventional delivery vehicle
  • the method may also be practiced by bringing the receptors into contact with
  • the method may be practiced to cure or relieve the symptoms of a disease, illness, or condition, and may further comprise also treating the human or animal with a normal dose of a bioactive substance delivered through the bloodstream to cure or relieve the symptoms of the same disease, illness, or condition
  • the method may be practiced to cure or relieve the symptoms of a disease illness, or condition conventionally treatable by delivering a bioactive system to the human or animal through the bloodstream, and further practiced with at least substantially the same positive effectiveness as the conventional treatment
  • the invention may be utilized so as to cure or relieve the symptoms of an almost unlimited number and type of conditions or illnesses, for example ADHD, ADD, nervousness, hot flashes, anxiety, insomnia, bone density loss, drug addiction, etc
  • a method of treating a human or animal with a disease illness, or condition to cure or relieve the symptoms thereof by bringing into contact with the human's or animal's gustatory receptors at least one bioactive substance in the amount of only between about 8 x 10 6 to 5 x 10 13 grams, or 5-10 microliters of about 6 7 x 10 s to 2 5 x 10 15 molar solution
  • an ingestible delivery vehicle containing only about 8 m ⁇ crograms-0.5 pic
  • the bioactive substances may be selected from the group consisting essentially of Chinese medicine herbal substances, mother of pearl, stimulants, and the other materials listed hereafter.
  • the delivery vehicle may be selected from the group consisting essentially of carbohydrate-based wafers, non- carbohydrate-based wafers, lozenges including lactose pellets, and capsules including gelatin capsules.
  • the bioactive substance may be sprayed onto the delivery vehicle, dripped on it, or otherwise provided on or in it.
  • the delivery vehicle may comprise only a single bioactive substance, or at least one bioactive substance comprises a plurality of bioactive substances collectively present in the amount of only about 8 micrograms - 0.5 picograms.
  • the total amount of bioactive substance in the one, or plurality, of bioactive substances may be any narrower range within the broad range set forth above, such as about 1 x 10 "9 to 1 x 10 " grams, or about 5-10 microliters of about 1 x 10 "10 to 1 x 10 ⁇ 13 molar solution.
  • the at least one bioactive substance comprises a formulation comprising Acanthopenax Root Bark, Schizand ⁇ a Chinensis, Concha Margarita, and Pe ⁇ carpium Citrus Reticulata.
  • FIGURE 1 is a schematic, block diagram showing a procedure for production and use of an ingestible delivery vehicle for a bioactive substance according to the invention
  • FIGURE 2 is a schematic view of a plurality of some of the exemplary delivery mechanisms according to the present invention.
  • the crude material for the production of nanodose treatments according to the invention is processed by typical Chinese standards and formulated for dispensing as an herbal supplement.
  • treatment is used herein means any bioactive substance used in health care.
  • the raw material is placed in a mortar and ground until it's a fine powder (approx. 1 hour).
  • the bioactive material is then extracted (11 ).
  • the powder from 10 is placed in a well-sealed bottle in a proportion of one (1) part powder to four (4. parts distilled water and four (4) parts ethanol (95%)
  • the preparation is sealed then placed in a warm water bath (e.g. about 37°C, so as to create a stable environment in which the active molecules are not over or under excited). This should be maintained for about one (1 ) hour
  • the bottle should then be stored at normal room temperature (about 20-25 " C) for 1 to 8 weeks Before decanting and filtering the bottle is shaken vigorously (e.g. for 64 shakes)
  • This preparation is labeled a nanodose extract (nDE) of the products name
  • the subsequent preparation is made by dilution (12). For example, by taking eight (8) parts of the nDE, adding sixty-four (64) parts 90% ethanol in a well-sealed bottle, and shaking vigorously (e g. for 64 shakes). This product is labeled 2nD which corresponds to 1.4 x 10 3 . Further dilutions (in 12) may be as described below
  • the third preparation is made by taking eight (8) parts of the 2nD adding sixty-four (64) parts 90% ethanol in a well-sealed bottle, and shaking vigorously (e g for 64 shakes) This product is labeled 3nD which corresponds to 1.5 x 10 "4 .
  • the fourth preparation is made by taking eight (8) parts of the 3nD adding sixty-four (64) parts 90% ethanol in a well sealed bottle, and shaking vigorously for 64 shakes This product is labeled 4nD which corresponds to a 1 7 x 10 5
  • the fifth preparation is made by taking eight (8) parts of the 4nD adding sixty-four (64) parts 90% ethanol in a well sealed bottle and shaking vigorously (e g for 64 shakes) This product is labeled 5nD which corresponds to a 1 9 x 10 6
  • the sixth preparation is made by taking eight (8) parts of the 5nD adding sixty-four (64) parts 90% ethanol alcohol in a well sealed bottle and shaking vigorously (e g for 64 shakes) This product is labeled 6nD which corresponds to a 2 0 x 10 7
  • nD preparation is misted or otherwise applied (see 13 in FIGURE 1 ), onto the carrier or vehicle of choice, e g wafers sucrose or lactose pellets gelatin capsules or any other conventional ingestible delivery vehicle in a proportion of about 10% (v/w), and/or such as described in co-pending application serial no 09/270,820
  • the liquid from 12 can be (13) sprayed, dripped on or otherwise placed on or in a delivery vehicle such as a wafer (14 - see FIGURE 2) lozenge (such as a sucrose pellet 15), capsule (16) or any other suitable delivery vehicle that can be retained and dissolved in a human s or animal s mouth, so that the bioactive substance is brought into contact with the gustatory or gustatory and olfactory, receptors
  • the amount of bioactive substance in the delivery vehicle (14-16) is only an amount effective to neurostimulate the human s or animal's
  • bioactive substance More than one bioactive substance may be incorporated in the delivery vehicle (14- 16), and each bioactive substance or all the bioactive substances collectively may be in the 8 x 10 6 - 5 x 10 13 grams range
  • the delivery vehicle (14-16) is used for treatment (17 - FIGURE 1 ) of ⁇ iseases illnesses or conditions, that is to cure them or relieve the symptoms thereof
  • Treatment according to the invention is typically at least substantially as effective as treatment with the same bioactive substances delivered through the bloodstream, and usually has much quicker action and there are less chances for side effects
  • Two, of the many, bioactive substances that may be utilized in the practice of the present invention are the complex formulations disclosed in U S patents 5,874,084, 5,834,000, and 5,807,554 (the disclosures of which are incorporated by reference herein), although almost any pharmacological, herbal supplement, or other bioactive substance may be effectively utilized according to the present invention
  • That composition is sold under the trade name "B- Quiet” and includes acanthopanex root bark schizandra chinensis, concha marga ⁇ ta (mother of pearl obtained from fresh water mollusks),
  • a forty-nine-year-old white female M D was having a nervous and fidgety episode She took one B-Quiet 3nD wafer produced according to the above-described method, and was calm and relaxed within minutes
  • bioactive substances include ACE innibitors adenohypophoseal hormones, adrenergic neuron blocking agents, adrenocortical steroids, inhibitors of the biosynthesis of adrenocortical steroids, alpha-adrenergic agonists, alpha-adrenergic antagonists, selective alpha-two-adrenergic agonists, analgesics antipyretics and anti-infiammatory agents, a ⁇ drogens local and general anesthetic
  • terbutaiine alclometasone, aidosterone, amcinonide, beclomethasone dipropionate, betamethasone, clobetasol.
  • ciocortolone cortisol, cortisone, corticosterone, desonide, desoximetasone, 1 1 -desoxycorticosterone, 1 1 -desoxycortisol, dexamethasone, diflorasone, fludrocortiso ⁇ e, flunisolide, fluocinolone, fluocinonide, fluorometholone, flurandrenolide. halcinonide, hydrocortisone.
  • etomidate fentanyl, halothane, isoflurane, ketamine hydrochloride, meperidine, methohexital. methoxyflura ⁇ e. morphine, propofol, sevoflurane, sufentanil, thiamylal, thiopental. acetaminophen, allopurinol, apazone, aspirin, auranofi ⁇ . aurothioglucose, coichicine, diclofenac. diflunisal, etodolac, fenoprofen, flurbiprofen, gold sodium thiomalate, ibuprofen.
  • indomethacin ketoprofen, meclofe ⁇ amate, mefenamic acid, meselamine, methyl salicylate. nabumetone, naproxen, oxyphenbutazone, phenacetin, phenylbutazone.
  • piroxicam salicylamide. salicylate, salicylic acid, salsalate, sulfasalazine, sulindac. tolmetin, acetophenazine, chlorpromazine, fluphenazine, mesoridazine, perphenazine, thioridazine, trifluorperazine, triflupromazine, disopyramide. encainide, flecainide, indecai ⁇ ide.
  • mexiletine moricizine, phenytoin, procainamide, propafenone, quinidine, tocainide.
  • cisapride domperidone, dronabinol, haloperidol, metoclopramide, nabilone, prochlorperazine, promethazine, thiethylperazine, trimethobe ⁇ zamide, buprenorphine, butorphanol.
  • bioactive substances include benzodiazepines, such as alprazolam, brotizolam, chlordiazepoxide, clobazam, clonazepam, clorazepate, demoxepam, diazepam, flumazenil flurazepam, halazepam, lorazepam, midazolam, nitrazepam, nordazepam, oxazepam, prazepam, quazepam, temazepam, t ⁇ azolam, and the like, an antimuscarinic agent such as anisotropine, atropine, clidinium, cyclopentolate, dicyclomme, flavoxate, glycopyrrolate hexocyc um, homatropine,
  • an estrogen such as chlorot ⁇ anisene, siethylstilbestrol, methyl estradiol, estrone, estrone sodium sulfate, estropipate mestranol, quinestrol, sodium equilin sulfate, 17. beta.
  • estradiol or estradiol
  • semi-synthetic estrogen derivatives such as the esters of natural estrogen, such as estrad ⁇ ol-17.beta -enanthate, estrad ⁇ ol-17.beta.-valerate, estrad ⁇ ol-3-benzoate, estradiol- 17.beta.-undecenoate, estradiol 16,17-hem ⁇ succ ⁇ nate or estrad ⁇ ol-17.beta -cypionate, and the 17-alkylated estrogens such as ethinyl estradiol, ethinyl estrad ⁇ ol-3- isopropylsulphonate, and the like, an androgen such as danazol, fluoxymesterone, methandrostenolone, methyltestosterone, nandrolone, nandrolone decanoate, nandrolone phenpropionate, oxandrolone, oxymetholone, sta ⁇ ozolol
  • testolactone testosterone, testosterone cypionate testosterone enanthate, testosterone propionate and the like; or a progestin such as ethyno ⁇ iol diacetate.
  • a progestin such as ethyno ⁇ iol diacetate. gestodene, hydroxyprogesterone caproate, levonorgestrel, medroxyprogesterone acetate, megestrol acetate, norethindrone, norethindrone acetate, norethynodrel, norgestrel, and progesterone.
  • bioactive substances include: adrenocortical steroid; adrenocortical suppressant, aldosterone antagonist ammo acid; anabolic: androgen; antagonist; anthelmintic; anti-acne agent, anti-adrenergic; anti-allergic; anti-amebic; anti-androgen; anti-anemic, anti-anginal, anti-arthritic; anti-asthmatic; anti-atherosclerotic antibacterial; anticholelithic, anttchoie thogenic.
  • anticholinergic anticoagulant, anticoccidal, antidiabetic, antidiarrheal, antidiuretic antidote; anti-estrogen; antifib ⁇ nolytic; antifungal, antiglaucoma agent; antihemophi c antihemorrhagic, antihistamine; antihyperlipidemia antihyperlipoproteinemic, antihypertensive, antihypotensive, anti-infective anti-infective, topical; anti-inflammatory: antikeratinizmg agent, antimala ⁇ al; antimicrobial; antimitotic, antimycotic, antineoplastic, antineutropenic, antiparasitic, antipe ⁇ staltic, antipneumocystic; antiproliferative; antiprostatic hypertrophy; antiprotozoal; antipruritic; antipsoriatic; antirheumatic; antischistosomal; antiseborrheic; a ⁇ tisecretory; antispasmod
  • Bos taurus (bubalus bubalis) gmelin mu huang
  • Cimicifuga dahurica (foetida), sheng ma. Cinnamomum cassia, (burmanni), rou gui.
  • Cinnamomum cassia, (chingii), gui pi Cinnamomum cassia, (chingii), gui pi.
  • Citrus medica xiang yuan.
  • Citrus medica (sarcodactylis) fo shou.
  • Clematis armandii (montana). chuan mu tong.
  • Clematis chinensis (hexapetala), wei ling xian Clinopodium gracile, jian dao cao.
  • Clinopodium polycephalum (chinense) duan xue liu.
  • Cryptotympana pustulate chan tui. Curculigo orchioides, xian mao.
  • Curcuma longa (wenyulin), yu jin. Cuscuta chinensis, tu si zi.
  • Ephedra sinica ma huang.
  • Eucalyptus globulus (robusta), an ye.
  • Euphorbia humifusa di jin cao. Euphorbia kansui , gan sui.
  • Eupolyphaga sinensis tu bie chong.
  • Fraxinus chinensis (rhynchophylla), qin pi.
  • Gallus gallus domesticus ji nei jin.
  • Gastrodia elata tian ma. Gaultheria yunnanensis, tou gu xiang.
  • Hedyotis diffusa bai hua she she cao.
  • Hemiboea subcapitata xiang long cao.
  • Hibiscus mutabilis fu rong hua.
  • Hibiscus syriacus mu jin hua.
  • Hordeum vulgare mai ya. Houftuynia cordata, yu xing cao.
  • Hypericum sampsonii yan bao cao. Ilex cornuta, gou gu ye.
  • Imperata cylindrical bai mao gen Imperata cylindrical bai mao gen.
  • Lycium chinense (barbarum), di gu pi.
  • Lycium barbarum gou qi zi. Lycopodium japonicum, shen jin cao.
  • Lysimachia trientaloides zhui feng san. Macaca mulatta, mi hou gu.
  • Magnolia denudata, (liliflora), xin yi hua Magnolia denudata, (liliflora), xin yi hua.
  • Notopterygium incisum qiang huo.
  • Origanum vulgare niu zhi.
  • Paeonia lactiflora bai shao.
  • Paeonia lactiflora, (veitchii) chi shao.
  • Phellodendron chinense (amurense), huang bai.
  • Picrorhiza scrophulariifolia hu huang lian.
  • Pinellia ternata ban xia. Pinus tabulaeformis, (massoniana) song jie.
  • Pogostemon cablin guang huo xiang.
  • Polygonum aviculare bian xu. Polygonum capitatum, tou hua liao.
  • Polygonum chinense hou tan mu.
  • Polygonum multifiorum he shou wu, shou wu teng. Polygonum orientate, hong cao.
  • Portulaca oleracea ma chi xian. Potentilla chinensis. wei ling cai.
  • Pueraria lobata (thomsonii). ge gen. Pulsatilla chinensis. bai tou weng.
  • Raphanus sativus iai fu zi.
  • Rhododendron molle Rhododendron molle, nao yang hua.
  • Sedum sarmentosum Sedum sarmentosum, chui pen cao. Selaginella tamriscina, juan bai.
  • Sinapis alba (Brassica juncea), jie zi.
  • Solidago decurreus yi zhi huang hua.
  • Sophora flavescens ku shen. Sophora japonica, huai hua.
  • Sophora tonkinensis, shan dou gen Sophora tonkinensis, shan dou gen.
  • Talinum paniculatum, tu ren shen Talinum paniculatum, tu ren shen.
  • Taxillus sutchuenensis sang ji shen. Tenodera sinensis, sang piao xiao.
  • Tinospora sagittata jin guo Ian. Thalictrum glandulosissimum, ma wei huang lian.
  • Thamnolia vermicularis Thamnolia vermicularis, xue cha.
  • Torricellia angulata (intermedia), shui dong gua.
  • Typhonium giganteum bai fu zi. Uncaria rhynchophylla, gou teng.
  • Vespertilio superana, ye ming sha Vespertilio superana, ye ming sha.
  • Viola yedoensis zi hua di ding.
  • Viscum album (coloratum), hu ji sheng.
  • Vitex negundo (cannabifolia), mu jing. Vitex trifolia, (simplicifolia), man jing zi. Viadimiris souliei, chuan mu xiang. Wikstroemia indica, liao ge wang.
  • bioactive substances that may be used include:
  • Echinacea Purpurea Echinacea purpurea
  • Appropriate combinations of these herbal and/or pharmaceutical formulations in a nanodose preparation may be used therapeutically to treat allergic disorders, cardiovascular system disorders, central nervous system disorders, dermatological conditions, ear disorders, endocrine system disorders, eye disorders, gastrointestinal tract disorders, immune system -disorders, infections, musculoskeletal disorders, neoplasms, obstetric/gynecological disorders, pain and pyrexia, drug dependence, respiratory tract disorders, surgical post-operative conditions, and urogenital system disorders.

Abstract

Treatment of human or animal diseases, illnesses, and conditions may be effectively practiced by administering extremely small dosages of bioactive substances which cause a 'trigger effect'. By neurostimulating the human's or animal's brain one effects a positive physical manifestation by substantially solely influencing the human's or animal's gustatory, or gustatory and olfactory, receptors. This is typically accomplished using a delivery vehicle (such as a wafer, lozenge, or capsule) containing only between about 8 micrograms and 0.5 picograms (or about 5-10 microliters of about 6.7 x 10-8 to 2.5 x 10-15 molar solution) of the bioactive substance, and treatment is essentially as effective as if the same bioactive substance was used in conventional treatment of a patient, through the bloodstream.

Description

DELIVERY OF SMALL DOSES OF INGESTIBLE TREATMENTS
CROSS REFERENCE TO RELATED APPLICATION
This application is based upon provisional application serial no 60/155,586 filed September 24, 1999, the disclosure of which is hereby incorporated by reference herein.
BACKGROUND AND SUMMARY OF THE INVENTION
In co-pending application Serial No 09/270,820 filed March 18, 1999 (the disclosure of which is hereby incorporated by reference herein), a novel method of delivering a medicinal or food supplement is described The delivery system involves a vehicle that may comprise a wafer that may be used in the practice of the method a method of making an approximately one hundred thousand-fold attenuation depending on the particular medicinal or food supplement, and a method of introducing the vehicle containing the attenuation As the active chemical constituents of an herbal formula are generally present in the range of about 0 1 % (for most herbs) - 80% (for certain herbs with a very high molecular weight bioactive substance) of the total weight of the herbal extracts, and the range of attenuation used in the preparation of the medicinal or food supplement ranges from between about 10 3 to 107, and the amount of diluted material applied to the delivery vehicle is 5-10 microliters, this invention delivers from 8 x 105 to 5 x 10 13 grams of an active substance or substances to a human or other mammal in order to get desirable results in the treatment of many illnesses, conditions and maladies The term coined herein (and it is a coined term, not previously known to have been used to describe small doses) to describe the delivery of these quantities of material to get the desirable results is nanodose It should be noted that because the molecular weights of the active constituents of the remedy are in the range of from 200 daltons to 15 000 daltons in the case of certain polysacchaπdes and glycoproteins, the molar concentration of the material in the 5-10 microliters delivered ranges from about 6 7 x 108 molar to 2 5 x 10 15 molar While in the practice of that method some active ingredient may be delivered to the bloodstream, it has been recognized that given the dilute nature of the active ingredient that is delivered, delivery by the bloodstream likely cannot account for the extremely successful results Therefore an evaluation was made as to what other mechanisms might be involved
According to the previous invention (co-pending application Serial No 09/270 820), it has been determined that by orally administering an amount of remedy that is similar to the amount found in a nanodose and using water or saliva as a pathway, and using sugar, or other carbohydrate delivery systems or the non-carbohydrate based wafer described in the above mentioned co-pending application, that effective treatment of many illnesses and conditions can be effected directly through the nervous system without any significant initial involvement by the bloodstream In that invention, Chinese hercs or other bioactive materials are present in a dilute enough form so that the structured water clusters formed from the ionic and dipolar properties of the biologically active substance exist in a stable form One can then stimulate gustatory receptors, which in turn results in nerve impulse propagation to the rostral nucleus of the solitary tract, where the neural message is encoded, and the coded information is relayed to the gustatory or insular cortex where the information is further encoded Efferent signals from these areas are relayed to appropriate neurons in the mbic and hypothalamic regions, where neurotraπsmitters are released that affect cortical, endocrine, autonomic and other central nervous system pathways, so that without requiring initial involvement of the bloodstream, an illness disorder, or other malfunction may be treated and reversed It should be noted that there can be subsequent involvement of the bloodstream due to neural induction of biochemical production and secretions
The historic and technical background related to and explaining the taste stimuli, brain stem and cerebral cortex involvement, and subsequent modification of hypothalamic and mbic responses are set forth in the following discussions Some Chinese remedies that have been used clinically for convulsions and seizures contain chemical compounds that inhibit excitatory glutamate transmission via calcium channel blockage It is expected that a nanodose prepared from such a remedy would act by inhibiting the appropriate excitatory synapses, gaining access via gustatory neurophysiological pathways While, as stated above, the quantity of bioactive molecules in a nanodose preparation is on the order of from 8 micrograms to 0 5 picograms (10 12 gm ) The quantity of active water cluster structures in that preparation is perhaps much higher Because of the preparation procedure used for nanodoses, to be described below, it is likely that the nanodose solution that is applied to the delivery vehicle contains much higher concentrations of microcrystalline structures that are composed solely of water molecules. The structures reflect the electronic and geometric properties of the original bioactive molecule Such ice-like structures form under enormously high electrostatic pressures that are generally neglected when considering the hydratioπ of molecules and ions in aqueous solution. Such stable water clusters possess magnified electric dipole moments and contain considerable crystal lattice energy which may be imparted to cell membrane receptor molecules upon interaction The tongue is perhaps the first sensory organ that comes in contact with a dose of medicine Modern pharmacology, with its emphasis on delivery of bio-active substances through the bloodstream, has neglected the first therapeutic agency in the human body Indeed, the neural pathways from tongue and mouth to the brain are more direct than the humoral delivery of regular contemporary medicines and likely safer Nanodoses are typically applied according to the invention substantially directly to sensory receptors on the tongue, or elsewhere in the mouth, such that they reach the taste buds through the saliva
Stimulation of these gustatory receptors is known to cause either a change in ion flux or the activation of a G-protein coupled response in the membrane of the taste cell, depending on the stimuli This stimulation initiates signal transduction mechanisms which result in the propagation of nerve impulses along primary afferent nerve fibers
These primary afferents terminate in the rostral nucleus of the tractus solaπus (rNTS), in the brainstem The terminal synapse of the primary afferents when they converge at the rNTS is thought to be a glutamate synapse Glutamate synapses are excitatory synapses that function via balancing of the excitatory action of the glutamate with the inhibitory action of gamma ammo butyric acid (GABA)
If two different areas of the tongue are stimulated, l e , two different types of gustatory receptors are stimulated, the signal that reaches the rNTS at the glutamate/GABA synapse is a complex summation of the signal seen when the two areas are stimulated individually This accounts for the complex actions of the many nanodose preparations that are made from multiple components In the NTS there are also neurons containing adrenergic and mu-opioid synapses As these types of neurons are involved in sugar utilization and feeding behavior, respectively, they are expected to be responsive to gustatory cues given in nanodose form There is evidence of neural projections from the NTS to the amygdala The limbic area, which includes the amygdala and the hippocampus is known to be involved in depression, anxiety, emotions some types of learned behaviors, motivation, sexual and hedonistic behavior, feeding behavior, and fear
Some of the neural information coded in the rNTS is thought to be relayed to an area of the insular cortex sometimes referred to as the gustatory cortex, largely by glutamate/GABA coding In fact, the induction of magnetic fields in response to gustatory stimuli have been detected in this region of the brain
From the gustatory cortex, information is sent to mbic and hypothalamic areas of the brain Areas of the hypothalamus are known to be involved in maintaining circadian rhythms, control of autonomic function dietary behavior, control of blood pressure, electrolyte concentrations, thermoreguiation immune responses, reproduction, and pituitary secretion of endocrine hormones, among other things
As indicated above, the active chemical constituents of nanodose preparations have been diluted so that the quantity of bioactive molecules is on the order of about 8 micrograms - 0 5 picograms This is the approximate amount of the active substance that is applied to the caroohydrate or non-carbohydrate delivery vehicle (wafer, lactose pellet gelatin capsule) etc The only known substances active at this level in whole animal bloodstreams are extremely active neurotoxins, which are not in the class of inherently beneficial bioactive substances according to the invention
Thus substantially the only delivery mechanism for treatments according to the invention is influencing the gustatory (and possibly olfactory) receptors, which neurostimulate the brain so as to effect a positive physical manifestation in a human or animal (typically mammal) patient That is the bloodstream is not involved in the basic delivery mechanism according to the invention but rather there is a trigger effect provided by, relatively speaking, only a few molecules While in some circumstances treatment according to the invention may be followed up with more conventional treatments involving delivery through the bloodstream or nasal passageways, for many bioactive materials only treatment according to the invention need be employed
Treatment according to the invention has numerous advantages over conventional pharmacological or focd supplement treatments These advantages include much reduced expense (highly significant for some materials now costing on the order of S25-$100, or more per dose), wider-spread effective utilization of rare bioactive substances, speed of action, and significant reduction (if not elimination) of adverse side effects, while still obtaining at least substantially the same positive effectiveness of treatment
In the practice of the present invention it is believed that if too much bioactive substance is delivered at a single point in time that the "trigger effect" achieved according to the invention does not occur Therefore there is a practical limit as to the maximum amount of bioactive substance that can be delivered at one time to get the desired results according to the invention While this amount may be dependent upon the particular bioactive substance delivered, it is believed that for most, if not all, bioactive substances the upper limit is about 8 micrograms Tne minimum amount that will result in the ' trigger effect" also may be substance-dependent , but is believed to be about 0 5 picograms The "trigger effect' according to the invention results in at least substantially the same positive effectiveness of treatment for a particular bioactive substance as if the normal dose of the same bioactive substance was delivered through the bloodstream According to one aspect oτ the present invention there is provided a method of treating a human or animal by neurostimulating the human's or animal's brain to effect a positive physical manifestation by substantially solely influencing the human's or animal's gustatory or gustatory and olfactory receptors
The method as described above may be practiced so as to influence substantially only the gustatory receptors, by bringing the gustatory receptors into contact with only between about 8 micrograms and 0 5 picograms (or about 5-10 microliters of about 6 7 x 108 to 2 5 x 10 1° molar solution) of a bioactive substance or any other narrower range within that broad range including (but not limited to) 1 x 109 to 1 x 10 11 grams For example the bioactive substance may be applied on or incorporated with a delivery vehicle that is adapted to be dissolved in a human's or animal's mouth and brought into contact with the gustatory receptors on tne tongue and other portions of the mouth perhaps also with olfactory receptor involvement For example the bioactive substance may be produced by dilutions using conventional Chinese standards and formulations for dispensing herbal supplements, and then may be sprayed on or incorporated in a wafer, lozenge capsule or other conventional delivery vehicle The method may also be practiced by bringing the receptors into contact with a plurality of bioactive substance collectively in an amount of only between about 8 micrograms and 0 5 picograms, an effective amount of the at least one bioactive substance being brought into contact with the gustatory receptors foi example by using a delivery vehicle Alternatively for some treatments the diluted bioactive substance in the amounts indicated above can be sprayed onto the patient's tongue
Typically the method is practiced so that the positive effectiveness of treatment is substantially the same as if the human or animal was treated with a normal dose of the at least one bioactive substance delivered through the bloodstream
For example the method may be practiced to cure or relieve the symptoms of a disease, illness, or condition, and may further comprise also treating the human or animal with a normal dose of a bioactive substance delivered through the bloodstream to cure or relieve the symptoms of the same disease, illness, or condition
Alternatively or in addition the method may be practiced to cure or relieve the symptoms of a disease illness, or condition conventionally treatable by delivering a bioactive system to the human or animal through the bloodstream, and further practiced with at least substantially the same positive effectiveness as the conventional treatment The invention may be utilized so as to cure or relieve the symptoms of an almost unlimited number and type of conditions or illnesses, for example ADHD, ADD, nervousness, hot flashes, anxiety, insomnia, bone density loss, drug addiction, etc According to another aspect of the present invention there is provided a method of treating a human or animal with a disease illness, or condition, to cure or relieve the symptoms thereof by bringing into contact with the human's or animal's gustatory receptors at least one bioactive substance in the amount of only between about 8 x 106 to 5 x 10 13 grams, or 5-10 microliters of about 6 7 x 10 s to 2 5 x 10 15 molar solution According to yet another aspect of the present invention there is provided an ingestible delivery vehicle containing only about 8 mιcrograms-0.5 picograms, or 6 7 x 10"8 to 2.5 x 10'15 molar of at least one bioactive substance.
In the delivery vehicles described above, the bioactive substances may be selected from the group consisting essentially of Chinese medicine herbal substances, mother of pearl, stimulants, and the other materials listed hereafter. The delivery vehicle may be selected from the group consisting essentially of carbohydrate-based wafers, non- carbohydrate-based wafers, lozenges including lactose pellets, and capsules including gelatin capsules. The bioactive substance may be sprayed onto the delivery vehicle, dripped on it, or otherwise provided on or in it.
The delivery vehicle may comprise only a single bioactive substance, or at least one bioactive substance comprises a plurality of bioactive substances collectively present in the amount of only about 8 micrograms - 0.5 picograms. The total amount of bioactive substance in the one, or plurality, of bioactive substances may be any narrower range within the broad range set forth above, such as about 1 x 10"9 to 1 x 10" grams, or about 5-10 microliters of about 1 x 10"10 to 1 x 10~13 molar solution. According to one specific example of the present invention, the at least one bioactive substance comprises a formulation comprising Acanthopenax Root Bark, Schizandπa Chinensis, Concha Margarita, and Peπcarpium Citrus Reticulata. It is the primary object of the present invention to provide a simple, advantageous and worthwhile delivery vehicle, and method of treating a human or animal, so as to optimize the treatment of illnesses, conditions, or diseases. This and other objects of the invention will become clear from an inspection of the detailed description of the invention and from the appended claims.
BRIEF DESCRIPTION OF THE DRAWINGS
FIGURE 1 is a schematic, block diagram showing a procedure for production and use of an ingestible delivery vehicle for a bioactive substance according to the invention and FIGURE 2 is a schematic view of a plurality of some of the exemplary delivery mechanisms according to the present invention.
DETAILED DESCRIPTION OF THE DRAWINGS
The crude material for the production of nanodose treatments according to the invention is processed by typical Chinese standards and formulated for dispensing as an herbal supplement. The term "treatment" is used herein means any bioactive substance used in health care.
In one exemplary procedure according to the invention, seen schematically at 10 in FIGURE 1 , the raw material is placed in a mortar and ground until it's a fine powder (approx. 1 hour).
The bioactive material is then extracted (11 ). For example, the powder from 10 is placed in a well-sealed bottle in a proportion of one (1) part powder to four (4. parts distilled water and four (4) parts ethanol (95%) The preparation is sealed then placed in a warm water bath (e.g. about 37°C, so as to create a stable environment in which the active molecules are not over or under excited). This should be maintained for about one (1 ) hour The bottle should then be stored at normal room temperature (about 20-25"C) for 1 to 8 weeks Before decanting and filtering the bottle is shaken vigorously (e.g. for 64 shakes) This preparation is labeled a nanodose extract (nDE) of the products name
The subsequent preparation is made by dilution (12). For example, by taking eight (8) parts of the nDE, adding sixty-four (64) parts 90% ethanol in a well-sealed bottle, and shaking vigorously (e g. for 64 shakes). This product is labeled 2nD which corresponds to 1.4 x 10 3. Further dilutions (in 12) may be as described below
The third preparation is made by taking eight (8) parts of the 2nD adding sixty-four (64) parts 90% ethanol in a well-sealed bottle, and shaking vigorously (e g for 64 shakes) This product is labeled 3nD which corresponds to 1.5 x 10"4.
The fourth preparation is made by taking eight (8) parts of the 3nD adding sixty-four (64) parts 90% ethanol in a well sealed bottle, and shaking vigorously for 64 shakes This product is labeled 4nD which corresponds to a 1 7 x 105 The fifth preparation is made by taking eight (8) parts of the 4nD adding sixty-four (64) parts 90% ethanol in a well sealed bottle and shaking vigorously (e g for 64 shakes) This product is labeled 5nD which corresponds to a 1 9 x 10 6
The sixth preparation is made by taking eight (8) parts of the 5nD adding sixty-four (64) parts 90% ethanol alcohol in a well sealed bottle and shaking vigorously (e g for 64 shakes) This product is labeled 6nD which corresponds to a 2 0 x 107
Even though these numbers 8 - 64 correspond to Chinese philosophy additional ranges such as 1 -64 could also be effective The nD preparation is misted or otherwise applied (see 13 in FIGURE 1 ), onto the carrier or vehicle of choice, e g wafers sucrose or lactose pellets gelatin capsules or any other conventional ingestible delivery vehicle in a proportion of about 10% (v/w), and/or such as described in co-pending application serial no 09/270,820 For example the liquid from 12 can be (13) sprayed, dripped on or otherwise placed on or in a delivery vehicle such as a wafer (14 - see FIGURE 2) lozenge (such as a sucrose pellet 15), capsule (16) or any other suitable delivery vehicle that can be retained and dissolved in a human s or animal s mouth, so that the bioactive substance is brought into contact with the gustatory or gustatory and olfactory, receptors The amount of bioactive substance in the delivery vehicle (14-16) is only an amount effective to neurostimulate the human s or animal's brain to effect a positive physical ani.estatioπ in the human or animal by substantially solely influencing the gustatory or gustatory or olfactory receptors For example the amount of bioactive substance in the delivery vehicles (14-16) is only between about 8 micrograms to 5 picograms, or between 6 7 x 10"8 to 2 5 x 10 15 molar
More than one bioactive substance may be incorporated in the delivery vehicle (14- 16), and each bioactive substance or all the bioactive substances collectively may be in the 8 x 10 6 - 5 x 10 13 grams range
The delivery vehicle (14-16) is used for treatment (17 - FIGURE 1 ) of αiseases illnesses or conditions, that is to cure them or relieve the symptoms thereof Treatment according to the invention is typically at least substantially as effective as treatment with the same bioactive substances delivered through the bloodstream, and usually has much quicker action and there are less chances for side effects Two, of the many, bioactive substances that may be utilized in the practice of the present invention are the complex formulations disclosed in U S patents 5,874,084, 5,834,000, and 5,807,554 (the disclosures of which are incorporated by reference herein), although almost any pharmacological, herbal supplement, or other bioactive substance may be effectively utilized according to the present invention In the following examples a commercial version of the product disclosed and claimed in some of the claims of U S patent 5,807,554 has been utilized That composition is sold under the trade name "B- Quiet" and includes acanthopanex root bark schizandra chinensis, concha margaπta (mother of pearl obtained from fresh water mollusks), and peπcarpium citrus reticulata The B-Quiet formulation was prepared according to the αetailed example described above (and described with respect to FIGURE 1 ) While it was not possible to measure the exact amount of the bioactive substances within the formulation which was sprayed onto a single wafer, from calculation based upon the amount of the initial material in the preparation procedures set forth above, the amount of bioactive substance is clearly within the range of 8 micrograms - 0 5 picograms, and is most likely within the range of 1 x 10 s to 1 x 10 11 grams In each of the following examples the B-Quiet formulation, in the annotated dose form applied to a wafer, was substantially as effective as treatments with B-Quiet formulation delivered through the bloodstream for similar conditions in other patients EXAMPLE 1 An eleven-year-old white male was diagnosed with ADHD He was having an unusually bad day with environmental stresses, acting out, and throwing tantrums His mother gave him one wafer of a Chinese herbal formula called B-Quiet 3nD produced according to the above-described procedure It was applied to his tongue Within a short time he had settled down She repeated this on two other occasions with the same results EXAMPLE 2
A forty-nine-year-old white female M D was having a nervous and fidgety episode She took one B-Quiet 3nD wafer produced according to the above-described method, and was calm and relaxed within minutes EXAMPLE 3 A nine-year-old white male was having a stressful time with a school project that led to bouts of crying He was given a B-Quiet 3nD wafer and was calm within minutes Examples of other bioactive substances (therapeutic agents) that may be used according to the invention include ACE innibitors adenohypophoseal hormones, adrenergic neuron blocking agents, adrenocortical steroids, inhibitors of the biosynthesis of adrenocortical steroids, alpha-adrenergic agonists, alpha-adrenergic antagonists, selective alpha-two-adrenergic agonists, analgesics antipyretics and anti-infiammatory agents, aπdrogens local and general anesthetics antiaddictive agents, antiandrogens, antiarrhythmic agents, antiasthmatic agents, anticholinergic agents antichoiinesterase agents, anticoagulants, antidiabetic agents antidiarrheal agents antidiuretic, antiemetic and prokinetic agents, antiepileptic agents antiestrogens, antifungal agents, antihypertensive agents, antimicrobial agents antimigraine agents antimuscarinic agents, antineoplastic agents, antiparasitic agents antiparkinson's agents antiplatelet agents antiprogestins antithyroid agents antitussives, antiviral agents, atypical antidepressants, azaspirodecanediones, barbituates benzodiazepines, benzothiadiazides beta-adrenergic agonists, betaadrenergic antagonists selective beta-one-adrenergic antagonists, selective beta-two-adrenergic agonists bile salts agents affecting volume and composition of body fluids, butyrophenones, agents affecting calcification, calcium channel blockers, cardiovascular drugs, catecholamines and sympathomimetic drugs cholinergic agonists, cholinesterase reactivators, dermatoiogical agents diphenylbutylpipeπdines diuretics, ergot alkaloids, estrogens, ganglionic blocking agents, ganglionic stimulating agents, hydantoins, agents for control of gastric acidity and treatment of peDtic ulcers, hematopoietic agents, histamines, histamine antagonists, 5-hydroxytryptamιne antagonists, drugs for the treatment of hyperlipoproteinemia, hypnotics and sedatives, immunosupressive agents, laxatives methylxanthines, monoamine oxidase inhibitors, neuromuscular blocking agents, organic nitrates, opiod analgesics and antagonists, pancreatic enzymes phenothiazines progestins prostaglandins agents for the treatment of psychiatric disorders, retinoids, sodium channel blockers, agents for spasticity and acute muscle spasms, succinimides, thioxanthines, thrombolytic agents thyroid agents tπcyciic antidepressants, inhibitors of tubular transport of organic compounds drugs affecting uterine motility, vasodilators, vitamins and the like Representative other bioactive substances are bepπdil, diltiazem, felodipine, isradipine, nicardipine, nifedipine nimodipine nitredipine, verapamii doDutamine, isoproterenol, carterolol, labetalol, levobunolol, nadolol, penbutolol, pindolol, propranolol, sotalol. timolol. acebutolol, atenolol, betaxolol, esmoiol, metoprolol, albuterol, bitolterol, isoetharine, metaproterenol, pirbuterol, ritodrine. terbutaiine, alclometasone, aidosterone, amcinonide, beclomethasone dipropionate, betamethasone, clobetasol. ciocortolone, cortisol, cortisone, corticosterone, desonide, desoximetasone, 1 1 -desoxycorticosterone, 1 1 -desoxycortisol, dexamethasone, diflorasone, fludrocortisoπe, flunisolide, fluocinolone, fluocinonide, fluorometholone, flurandrenolide. halcinonide, hydrocortisone. medrysone, 6.alpha.-methylprednisolone, mometasone, paramethasone, prednisoloπe, predπisone, tetrahydrocortisol, triamcinolone, benoxinate, benzocaine, bupivacaine, chloroprocaine, cocaine, dibucaine, dyclonine, etidocaine. Iidocaine. mepivacaine, pramoxine, prilocaine, procaine. proparacaine, tetracaine, alfeπtanil, choroform, clonidine, cyclopropane, desflurane, diethyl ether, droperidol, enflurane. etomidate, fentanyl, halothane, isoflurane, ketamine hydrochloride, meperidine, methohexital. methoxyfluraπe. morphine, propofol, sevoflurane, sufentanil, thiamylal, thiopental. acetaminophen, allopurinol, apazone, aspirin, auranofiπ. aurothioglucose, coichicine, diclofenac. diflunisal, etodolac, fenoprofen, flurbiprofen, gold sodium thiomalate, ibuprofen. indomethacin, ketoprofen, meclofeπamate, mefenamic acid, meselamine, methyl salicylate. nabumetone, naproxen, oxyphenbutazone, phenacetin, phenylbutazone. piroxicam, salicylamide. salicylate, salicylic acid, salsalate, sulfasalazine, sulindac. tolmetin, acetophenazine, chlorpromazine, fluphenazine, mesoridazine, perphenazine, thioridazine, trifluorperazine, triflupromazine, disopyramide. encainide, flecainide, indecaiπide. mexiletine, moricizine, phenytoin, procainamide, propafenone, quinidine, tocainide. cisapride, domperidone, dronabinol, haloperidol, metoclopramide, nabilone, prochlorperazine, promethazine, thiethylperazine, trimethobeπzamide, buprenorphine, butorphanol. codeine, dezocine, diphenoxylate, drocode, hydrocodone, hydromorphone, levallorphan, levorphanol, loperamide, meptazinol, methadone, nalbuphine, nalmefene, nalorphine. naioxone, naltrexone, oxybutynin, oxycodone, oxymorphone, pentazocine, propoxyphene, isosorbide dinitrate, nitroglycerin, theophyliine, phenylephrine, ephidriπe, pilocarpine. furosemide. tetracycline, chlorpheniramine, ketorolac, bromocriptine, guanabenz, prazosin, doxazosin, and flufenamic acid. Other representative bioactive substances include benzodiazepines, such as alprazolam, brotizolam, chlordiazepoxide, clobazam, clonazepam, clorazepate, demoxepam, diazepam, flumazenil flurazepam, halazepam, lorazepam, midazolam, nitrazepam, nordazepam, oxazepam, prazepam, quazepam, temazepam, tπazolam, and the like, an antimuscarinic agent such as anisotropine, atropine, clidinium, cyclopentolate, dicyclomme, flavoxate, glycopyrrolate hexocyc um, homatropine, ipratropium, isopropamide, mepenzolate. methantheline, oxyphencyc mine, pirenzepine, propantheline, scopolamine, teleπzepine, tπdihexethyl. tropicamide, and the like: an estrogen such as chlorotπanisene, siethylstilbestrol, methyl estradiol, estrone, estrone sodium sulfate, estropipate mestranol, quinestrol, sodium equilin sulfate, 17. beta. -estradiol (or estradiol), semi-synthetic estrogen derivatives such as the esters of natural estrogen, such as estradιol-17.beta -enanthate, estradιol-17.beta.-valerate, estradιol-3-benzoate, estradiol- 17.beta.-undecenoate, estradiol 16,17-hemιsuccιnate or estradιol-17.beta -cypionate, and the 17-alkylated estrogens such as ethinyl estradiol, ethinyl estradιol-3- isopropylsulphonate, and the like, an androgen such as danazol, fluoxymesterone, methandrostenolone, methyltestosterone, nandrolone, nandrolone decanoate, nandrolone phenpropionate, oxandrolone, oxymetholone, staπozolol. testolactone, testosterone, testosterone cypionate testosterone enanthate, testosterone propionate and the like; or a progestin such as ethynoαiol diacetate. gestodene, hydroxyprogesterone caproate, levonorgestrel, medroxyprogesterone acetate, megestrol acetate, norethindrone, norethindrone acetate, norethynodrel, norgestrel, and progesterone.
Among other bioactive substances are: adrenocortical steroid; adrenocortical suppressant, aldosterone antagonist ammo acid; anabolic: androgen; antagonist; anthelmintic; anti-acne agent, anti-adrenergic; anti-allergic; anti-amebic; anti-androgen; anti-anemic, anti-anginal, anti-arthritic; anti-asthmatic; anti-atherosclerotic antibacterial; anticholelithic, anttchoie thogenic. anticholinergic, anticoagulant, anticoccidal, antidiabetic, antidiarrheal, antidiuretic antidote; anti-estrogen; antifibπnolytic; antifungal, antiglaucoma agent; antihemophi c antihemorrhagic, antihistamine; antihyperlipidemia antihyperlipoproteinemic, antihypertensive, antihypotensive, anti-infective anti-infective, topical; anti-inflammatory: antikeratinizmg agent, antimalaπal; antimicrobial; antimitotic, antimycotic, antineoplastic, antineutropenic, antiparasitic, antipeπstaltic, antipneumocystic; antiproliferative; antiprostatic hypertrophy; antiprotozoal; antipruritic; antipsoriatic; antirheumatic; antischistosomal; antiseborrheic; aπtisecretory; antispasmodic; antithrombotic; antitussive; anti-ulcerative; anti-urolithic; antiviral; appetite suppressant; benign prostatic hyperplasia therapy agent; bone resorption inhibitor; bronchodilator; carbonic anhydrase inhibitor; cardiac depressant; cardioprotectant; cardiotonic; cardiovascular agent; choleretic; choliπergic; cholinergic agonist; cholinesterase deactivator; coccidiostat; diagnostic aid: diuretic; ectoparasiticide; enzyme inhibitor; estrogen; fibrinolytic; free oxygen radical scavenger; glucocorticoid; gonad-stimulating principle; hair growth stimulant; hemostatic; hormone; hypocholesterolemic; hypogiycemic; hypolipidemic; hypotensive; immunizing agent; immunomodulator; immunoregulator; immunostimulant; imnunosuppressant; impotence therapy adjunct: inhibitor; keratolytic; LHRH agonist; liver disorder treatment, luteolysin; mucolytic; mydriatic; nasal decongestant; neuromuscular blocking agent; non-hormonal sterol derivative; oxytocic; plasminogen activator; platelet activating factor antagonist; platelet aggregation inhibitor; potentiator; progestin; prostaglandin; prostate growth inhibitor; prothyrotropin; pulmonary surface; radioactive agent; regulator; relaxant; repartitioning agent; scabicide; sclerosing agent; selective adenosine A1 antagonist; steroid; suppressant; symptomatic multiple sclerosis; synergist; thyroid hormone; thyroid inhibitor; thyromimetic; amyotrophic lateral sclerosis agents; Paget's disease agents; unstable angina agents: uricosuric; vasoconstrictor; vasodilator; vulnerary; wound healing agent; xanthine oxidase inhibitor.
The following Chinese herbal preparations also may be used as bioactive substances. These substances are listed in alphabetical order by their scientific name followed by the Chinese name in pinyin:
Abrus precatorius, xiang si zi. Abutilon theophrastii, qing ma zi.
Acacia catechu, er cha.
Acanthopanax gracilistylus , wu jia pi
Acanthopanax senticosus, ci wu jia.
Acanthopanax -trifoliatus, ci san jia. Acalypha australis, tie xian cai.
Achillea alpina, A.(wilisoniana), shi cao. Achyranthis bidentiatae, niu xi
Aconitum carmichaeli, chuan wu, (fu zi)
Aconitum hemsieyanum, teng cao wu.
Aconitum kunezoffii, cao wu. Acorus calamus, bai chang pu
Acorus gramineus, shi chang pu.
Adenophora tetraphylia, nan sha shen
Aesculus chinensis, suo luo zi
Agastache rugosa, huo xiang Agkistrodon acutus, qi she
Agrimonia pilosa, xian he cao
Ailanthus altissima, chu bai pi
Ajuga decumbens, bai mao xia ku cao
Akebia quinata, ba yue sha (yu zhi zi) Akebia trifoliata, mu tong
Alangium chinense, ba jiao feng
Albizzia julibrissin, he huan pi
Alisma orientalis, ze xie
Allium tuberosum, jiu zi Allobophora caliginosa, (pheretima asperillum), di long
Aloe barbadensis, lu hui
Alpinia galanga, hong dou kou
Alpinia katsumadai, cao dou kou
Alpinia officinarum, gao liang jiang Alpinia oxyphylia, yi zhi ren
Amomum kravanh, bai dou dou
Amomum tsao-ko, cao guo
Amomum villosum, (xanthioides) sha ren
Amydae sinesis, bie jia, Ampelopsis japonica, bai lian
Andrographis paniculata, chuan xin lian Anemarrhena asphodeloides. zhi mu.
Anemone altaica, jiu jie chang pu
Anemone hupehensis, da po wan hua hua
Anemone rivularis, hu zhang cao Angelica dahuricae, bai zhu
Angelica pubescens, du huo
Angelica sinensis, dang gui
Aquilaria sinensis, cheng xiang
Aralia chinensis, cong mu Aralia cordata, jiu yan du huo
Arctium lappa, niu bang zi
Ardisia crenata, zhu sha gen
Ardisia japoni Ca, ai di cha
Areca catechu , bing lang Arisaema amurense, (consanguineum), tian nan xing.
Aristolochia cinnabrina, chuan zhu sha lian
Aristolochia contorta, (debilis), ma dou ling
Aristolochia fangchi, guang fang ji
Aristolochia heterophylla, han zhong fang ji Aristolochia manshuriensis. guan mu tong
Arnebia euchroma. zi cao
Artemisia annua, qing hao
Artemisia argyi, ai ye
Artemisia scoparia, (capillaris), yin chen hao Asarum forbesii, du heng
Asarum heterotropoides, xi xin
Asparagus cochinchinensis, tian men dong,
Asparagus officinalis, shi diao bai
Aspongopus chinensis, jiu xiang Chong Aster tataricus , zi wan
Astragalus complanatus, sha yuan zi Astragalus membranaceus, huang qi
Atractylodes laπcea (chinensis), caπg zhu
Atractylodes macrcophala, bai zhu
Aucklandia lappa, mu xiang Bambusa textilis, zhu huang
Bambusa tuldoides, zhu ru
Baphicacanthus cusia, ma Ian
Belamcanda chinensis, she gan
Beπincasa hispida, dong gua pi Berbeπs sou eana, san ke zhen
Bergenia purpurascens, yan bai cao
Bidens pilosa, gui zhen cao
Biota onentalis (Platycladus onentalis), ce bai ye and bai zi ren
Bletilla stπatae, bai JI Blumea basamifera, bing pian
Boehmeπa nivea, zhu ma gen
Bombyx mon, bai Jiang can
Bos taurus (bubalus bubalis) gmelin mu huang
Botrychium ternatum yin di jue Brassica juncea (sinapis alba) jie zi
Broussonetia papyπfera, chu shi zi
Brucea javanica, ya dan zi
Bubalus bubalis , shui niu jiao
Buddleja officinalis, mi meng hua Bufo bufo gargaπzans, chan su
Bungarus multicmctus multicmctus, jin qian bai hua she
Bupleurum chmense, chai hu
Buthus martensii, quan xie
Caesalpmia sappan, su mu Callicarpa macrophylla, da ye zi zhu
Calvatia gigaπtea (lilacma), ma bo Camellia japonica, shen chan hua
Camellia sinensis, cha ye
Camptotheca acuminata, xi shu guo
Canarium album, qing guo Cannabis sativa, huo ma ren
Carpesium abrotanoides, he shi
Carthamus tinctorins, hong hua
Carica papaya, fan mu gua
Capparis masaikai, ma bing lang Capselia bursa-pastoris, ji cia.
Cassia acutifolia, (angustifolia) fan xie ye.
Cassia obtusifolia, (tora), jue ming zi.
Cassia occidentalis, wang jiang nan.
Cayratia japonica, wu lian mei. Celosia argentea, qing xiang zi.
Celosia cristata, ji guan hua.
Centipeda minima, e bu shi cao.
Cervus elaphus, (macueilli), ma lu rong.
Cervus nippon, hua lu rong. Cephalotaxus fortunei, san jian shan.
Chaenomeles speciosa, mu gua.
Changium smyrnioides, ming dang shen.
Chenopodium ambrosioides, tu jing jie.
Chimonanthus praecox, tie kuai zi. Chinemys reevesii, gui ban.
Chloranthus serratus, ji ji
Chrysanthemum indicum, ye ju hua
Chrysanthemum morifolium, ju hua.
Cibotium barometz, gou ji. Cicada flammata, (cordyceps cicadae), chan hua.
Cimicifuga dahurica, (foetida), sheng ma. Cinnamomum cassia, (burmanni), rou gui.
Cinnamomum cassia, (chingii), gui pi.
Cinnamomum migao. da guo mu jiang zi. Cirsium japonicum, da ji.
Cirsium segetum, xiao ji. Cistanche saisa , rou cong rong
Citrus aurantium, zhi qiao.
Citrus aurantium, zhi shi.
Citrus aurantium, dai dai hua.
Citrus medica, xiang yuan. Citrus medica, (sarcodactylis) fo shou.
Citrus reticulate, chen pi.
Citrus reticulate, qing pi.
Citrullus lanatus, xi gua pi.
Clematis armandii, (montana). chuan mu tong. Clematis chinensis, (hexapetala), wei ling xian Clinopodium gracile, jian dao cao.
Clinopodium polycephalum, (chinense) duan xue liu.
Cnidium monnieri, she chang zi.
Cocculus trilobus, mu fang ji.
Codonopsis pilosula, dang shen. Codonopsis tubulosa, qian dang shen.
Coix lachryma-jobi, yi yi ren.
Commelina communis, ya zhi cao.
Coptis chinensis, (teeta) huang lian, (we lian). Coptis deltoidea, ya lian.
Cordyceps sinensis, dong chong xia cao. Cornus officinalis, shan zhu yu. Corydalis yanhusuo, yan hu suo.
Crataegus pinnatifida, shan zha.
Crocus sativus, fan hong hua.
Crotalaria ferruginea, xiang ling cao.
Croton tiglium, ba dou. Cucurbita moschata, nan gua zi.
Cryptotympana pustulate, chan tui. Curculigo orchioides, xian mao.
Curcuma zedoaria, e zhu.
Curcuma loπga, jiang huang.
Curcuma longa, (wenyulin), yu jin. Cuscuta chinensis, tu si zi.
Cyathula officinalis. chuan niu xi.
Cynanchum atratum, bai wei.
Cynanchum auriculatum, ge shan xiao.
Cynanchum paniculatum, xu chang qing. Cynanchum stauntonii, bai qian.
Cyperus rotundus, xiang fu.
Dalbergia odorifera, jiang xiang.
Dracaena cambodiana, xue jie.
Daphne genkwa, yuan hua. Datura metel, (innoxia). yang jin hua.
Daucus carota, nan he shi.
Davidia involucrata, gong tong.
Dendrobium nobile, (loddigesii), shi hu.
Descurainia sophia, ting li zi. Dianthus chinensis. (superbus), qu mai.
Dichroa febrifuge, chang shan.
Dictyophora indusieta, zhu sun.
Dictamnus dasycarpus, bai xia pi.
Dimocarpus longan, long yan rou. Dioscorea bulbifera, huang yao zi.
Dioscorea cirrhosa, shu hang.
Dioscorea hypoglauca, fen bi xie.
Dioscorea opposita , shan yao.
Diospyros kake, shi di. Dipsacus asper, Oaponicus), xu duan.
Dolichos lablab, bian dou. Dracaena cambodiana, xue jie.
Drynaria fortunei, (baronii), gu sui bu.
Dysosma pleinatha, (versipellis), ba jiao lian.
Eclipta prostrate, mo han lian. Elaeagnus pungens, hu tui zi ye.
Elaphe taeniura, (carinata), she tui.
Emilia sonchifolia, yi than hong,
Ephedra sinica, ma huang.
Epimedium grandiflorum, (brevicornum), yin yang huo. Equus asinus, e jiao.
Eretmochelys imbricate, dai mao.
Equisetum hiemale, mu zei.
Ericerus pela, chong bai la.
Eriobotrya japonica, pi pa ye. Erodium stephanianum, lao guan cao.
Eucalyptus globulus,(robusta), an ye.
Eucommia ulmoides, du zhong ye.
Eugenia caryophyliata, ding xiang.
Euonymus alata, gui jian yu. Eupatorium fortunei, pei lian.
Eupatorium lindleyanum, ye ma zhui.
Euphorbia helioscopia, ze qi.
Euphorbia hirta, da fei yang.
Euphorbia humifusa, di jin cao. Euphorbia kansui , gan sui.
Euphorbia lathyris, qian jin zi.
Euphorbia pekinensis, da ji.
Eupolyphaga sinensis, tu bie chong.
Euryale ferox, qian shi. Evodia rutaecarpa. wu zhu yu.
Fagopyrum cymosum, jin qiao mai. Ficus carica, wu hua gua.
Ficus tikoua, di gua teng.
Firmiaπa simplex, wu tong zi.
Foeniculum vulgare, xiao hui xiang. Forsythia suspensa, lian qiao.
Fraxinus chinensis, (rhynchophylla), qin pi.
Fritillaria cirrhosa, chuan bei mu.
Fritillaria delarayi, lu bei mu.
Fritillaria thunbergii, zhe bei mu. Fritillaria ussuriensis, ping bei mu.
Gallus gallus domesticus, ji nei jin.
Ganoderma japonicum, (lucidum), ling zhi.
Gardenia jasminoides, zhi zi.
Gastrodia elata, tian ma. Gaultheria yunnanensis, tou gu xiang.
Gekko gecko, ge jie.
Gentiana macrophylla,(dahurica), qin jiao.
Gentiana scabra, (manshurica),(triflora), long dan.
Gentiana rhodantha, qing yu dan cao. Geum japonicum, (chinense), [an bu zheng.
Ginkgo biloba, bai guo
Ginkgo biloba, ren shen ye.
Glechoma longituba, lian qian cao.
Gleditsia sinensis, zao jiao ci. Glehnia liftoralis, bei sha shen.
Glochidion puberum, suan pan zi.
Glycine max, dan dou chi.
Glycyrrhiza uralensis, gan cao.
Gynostemma pentaphylium, jiao gu Ian. Haliotis diversicolor, shi jue ming.
Hedyotis diffusa, bai hua she she cao. Hemiboea subcapitata, xiang long cao.
Hemerocallis fulva, (citrina) xuan caa gen.
Hemsleya amabilis (chinensis), xue dan.
Hibiscus mutabilis, fu rong hua. Hibiscus syriacus, mu jin hua.
Hippocampus, hai ma.
Hirudo πipponica, shui zhi.
Homalomena occulfa, qian nian jian.
Hordeum vulgare, mai ya. Houftuynia cordata, yu xing cao.
Hovenia dulcis, zhi ju zi.
Humulus lupulus, hu bu hua.
Hydrocarpus antheimintica, da fang zi.
Hydrocotyle sibthorpioides, tian hu sui. Hyoscyamus niger, tian xian zi.
Hypericum ascyron, hong tian lian.
Hypericum erectum, xiao lian qiao.
Hypericum japonicum di er cao.
Hypericum sampsonii, yan bao cao. Ilex cornuta, gou gu ye.
Illicum verum, ba jiao hui xiang.
Impatiens balsamina, feng xian tou gu cao.
Imperata cylindrical bai mao gen.
Indigofera tinctoria, mu Ian. Inula helenium, tu mu xiang.
Inula japonica, xuan fu hua.
Isatis indigotica, (tinctoria), ban Ian gen.
Isatis indigotica, (tinctoria), da qing ye.
Jasminum officiπale, su xin hua. Juglans regia, hu tao ren.
Juncus effusus. deng xin cao. Kaempferia galanga, shan nai.
Kalime s indica, ma Ian cao.
Knoxia valerianoides, hong da ji.
Kochia scoparia, di fu zi. Lagenaria siceraria, hu lu.
Lasiosphaera fenzlii, ma bo.
Leonurus heterophyllus, yi mu cao.
Lepidogrammitis drymoglossoidies, bao shi lian.
Lepidium apetalum, ting li zi. Ligusticum chuanxiong, chuan xiong.
Lugusticum sinense, gao ben.
Ligustrum lucidum, nu zhen zi.
Lilium lancifolium, (brownii), bai he.
Lindera stychnifolia, (aggregate), wu yao. Liquidambra taiwaniana, lu lu tong.
Litchi chinensis, li zhi he.
Lobelia chinensis, ban bian lian.
Lonicera japonica, jin yin hua.
Lonicera japonica, ren dong teng. Lophatherum gracile, dan zhu ye.
Luffa cylindrical si gua teng.
Luffa cylindrical si gua luo.
Lycium chinense, (barbarum), di gu pi.
Lycium barbarum, gou qi zi. Lycopodium japonicum, shen jin cao.
Lycopus lucidus, ze Ian.
Lycoris radiata, shi suan
Lygodium japonicum, hai jin sha.
Lygodium japonicum, hai jin sha cao. Lysimachia christinae, jin qian cao.
Lysimachia trientaloides, zhui feng san. Macaca mulatta, mi hou gu.
Macleaya cordata, bo luo hui.
Magnolia denudata, (liliflora), xin yi hua.
Magnolia offici nalis, (biloba), hou po, hou po hua. Magnolia rostrata, da ye mu Ian.
Mahonia bealei, (fortunei), shi da gong lao ye.
Manis pentadactyl, chuan shan jia.
Melaphis chinensis, wu bei zi.
Melia azedarach, (toosendan), ku lian pi. Melia toosendan, chuan lian zi.
Menispermum dauricum, bei dou gen.
Mentha haplocalyx, bo he.
Meretrix meretrix, ge qiao.
Milleftia dielsiana, ya dou ten. Momordica cochinchinensis, mu bie zi.
Morinda officinalis, ba ji tian.
Morus alba, sang shen, sang zhi, sang bai pi, sang ye.
Moschus moschiferus, she xiang.
Mosla chinensis, xiang ru. Mylabris phalerata, (cichorii) ban mao.
Myrica rubra, yang mei.
Myristica fragrans, rou dou kou
Myrrha. mo yao.
Nandina domestics, nan tian zhu. Nardostachys chinensis, gan song.
Nelumbo nucifera, lian xin, lian fang, lian zi, he ye, ou jie
Notopterygium incisum, qiang huo.
Olibanum gummi, ru xiang.
Omphalia lapidescens, lei wan. Ophioglossum vulgatum, ping er xiao cao.
Ophiopogon japonicus, mai men dong. Opuntia dillenii, xian ren zhang.
Origanum vulgare, niu zhi.
Oroxylum indicum, mu hu die.
Oryza sativa, gu ya. Osbeckia crinita, chao tian guan.
Osmunda japonica, zi qi guan zhong.
Ostrea gigas, mu li.
Paederia scandens, ji shi teng.
Paeonia lactiflora, bai shao. Paeonia lactiflora, (veitchii) , chi shao.
Paeonia suffruticosa, mu dan pi.
Panax ginseng, reh shen.
Panax japonicus, zhu jie shen.
Panax notoginseng, san qi. Panax quinquefolium, xi yang shen.
Panthera pardus, bao gu.
Papaver somniferum, yiπg su ke.
Paris poiyphylia, chong lou.
Patiris pectinifera. hai yan. Perilla frutescens, zi su ye. zi su zi. su geng.
Peripioca forrestii, hei gu teng.
Peristrophe japonica, jiu tou shi zi cao.
Peripioca sepium, xiang jia pi.
Peucedanum decursivum, zi hua qian hu. Peucedanum praeruptorum, bai hua qian hu.
Pharbitis nil, (purpurea), qian niu zi.
Phaseolus calcaratus, (angularis), chi xiao dou.
Phellodendron chinense, (amurense), huang bai.
Pheretima aspergillum. di long. Phoca vitulina, hai gou shen.
Phragmites communis, lu gen. Phyllanthus emblica, yu gan zi.
Phytolacca acinosa, (americans), shang lu.
Picrorhiza scrophulariifolia. hu huang lian.
Pinellia ternata, ban xia. Pinus tabulaeformis, (massoniana) song jie.
Piper longum, bi bo.
Piper nigrum, hu jiao.
Pittosporum illicoides, shan zhi cha.
Plantago asiatica, che qian cao , che qian zi. Platycladus orientalis, ce bai ye, bai zi ren.
Platycodon grandiflorum, yuan zhi.
Pleioblastus amarus, ku zhu ye.
Pogostemon cablin, guang huo xiang.
Polistes mandarinus, feng fang. Polygala japonica, gua zi jin.
Polygala tenuifola, yuan zhi.
Polygonatum odoratum, yu zhu.
Polygonatum sibiricum, huang jing.
Polygonum aviculare, bian xu. Polygonum capitatum, tou hua liao.
Polygonum chinense, hou tan mu.
Polygonum cuspidatum, hu zhang.
Polygonum hydropiper, la liao.
Polygonum multifiorum, he shou wu, shou wu teng. Polygonum orientate, hong cao.
Polygonum perfoliatum, gang ban gui.
Polygonum runcinatum, hua hu die.
Polyporus umbellatus, zhu ling.
Polytrichum commune, tu ma zong. Poria cocos, fu ling , su shen.
Portulaca oleracea, ma chi xian. Potentilla chinensis. wei ling cai.
Potentilla discolor,, fan bai cao.
Prinsepia Uniflora, rui ren.
Prunella vulgaris. xia ku cao. Prunus armeniaca, ku xing ren.
Prunus japonica. yu li ren.
Prunus mume, wu mei.
Prunus persica, tao ren.
Pseudostellaria heterophylla. tai zi shen. Pseudosciaeπa crocea, yu nao shi.
Psoralea corylifolia. bu gu zhi.
Pteria margaritifera. (martensii), zhen zhu.
Pteris multifida, feng wei cao.
Pueraria lobata, (thomsonii). ge gen. Pulsatilla chinensis. bai tou weng.
Punica granatum, shi liu pi.
Pyrola rotundifolia, (chinensis), lu xian cao.
Pyrrosia sheareri, shi wei.
Quisqualis indica. shi jun zi. Rana temporaria chensinensis, ha mo you.
Raphanus sativus, iai fu zi.
Ranunculus japonicus, mao gen.
Rauvolfia verticillata, lu fu mu.
Rehmannia glutinosa, sheng di huang, Rhamnus leptophylla, jiang li zi.
Rheum paimatum, (officinale), da huang.
Rhododendron molle, nao yang hua.
Ricinus communis, bi ma zi.
Rosa chinensis, yue ji hua. Rosa laevigata, jin yin zi.
Rosa roxburghii, ci li. Rubia cordifolia , qian cao gen.
Rubus chingii, fu pen zi.
Rumex chalepensis, tu da huang.
Rumex japonicus, yang ti. Saiga tatarica, ling yang jiao.
Salvia cavaleriei, xue pen cao.
Salvia miltiorrhiza, dan she.
Sanguisorba officinalis, di yu.
Santalum album, tan xiang. Saposhnikovia devaricata, fang feng.
Sarcandra glabra, jiu jie cha.
Sargassum pallidum, (fusiforme), hai zao.
Saussurea laniceps, xue lian hua.
Saussurea lappa, mu xiang. Saxifraga stolonifera, hu er cao.
Sargentodoxa cuneata, hong teng.
Schisandra chinensis, wu wei zi.
Schizonepeta tenuifolia, jing jie.
Scolopendra subspinipes mutilans, wu gong. Scrophularia ningpoensis, xuan shen.
Scutellaria baicalensis, huang qin.
Scutellaria barbata, ban zhi lian.
Sedum aizoon, jing tian san qi.
Sedum sarmentosum, chui pen cao. Selaginella tamriscina, juan bai.
Semiaquilegia adoxoides, tian kui zi.
Selenarctos thibetanus,(Ursus arctos), xiong dan.
Sepia esculenta,(sepielia maindroni), hai piao xiao.
Sesamum indicum, hei zhi ma. Senecio scandens, qian li guang.
Serissa serissoides, liu yue xue. Setaria viridis, gou wei cao.
Siegesbeckia pubescens,(orientalis), xi xian cao.
Sinapis alba, (Brassica juncea), jie zi.
Smilax glabra, tu fu ling. Solanum lyratum, bai ying.
Solanum nigrum, long kui.
Solenognathus hardwickii, hai long.
Solidago decurreus, yi zhi huang hua.
Sophora flavescens, ku shen. Sophora japonica, huai hua.
Sophora tonkinensis, shan dou gen.
Sparganium stoioniferum, san leng.
Spatholobus suberectus, ji xue teng.
Spiraea japonica, (blumei), xiu xian ju.. Stachyurus himalaicus, (chinensis), xiao tong cao.
Stalactitum, zhong ru shi.
Stellaria dichotoma, (lanceolata), yin chai hu.
Stellera chamaejasme. xi bei lang du.
Stemona tuberosa, (sessilifolia) , bai bu. Stephania sinica, shan wu gui.
Stephania tetrandra, fen fang ji.
Sterculia lychnophora, pang da hai.
Stichopus japonicus, hai shen.
Strobilanthes cusia, qing dai. Strychnos nox-vomica, ma qian zi.
Syneilesis aconitifolia, tu er san.
Talinum paniculatum, tu ren shen.
Tamarix chinensis, cheng liu.
Taraxacum mongolicum, (sinicum).pu gong ying. Taxillus chinensis, guangji sheng.
Taxillus sutchuenensis, sang ji shen. Tenodera sinensis, sang piao xiao.
Terminalia chebula, he zi.
Tetrapaπax papyriferus, tong cao.
Tinospora sagittata. jin guo Ian. Thalictrum glandulosissimum, ma wei huang lian.
Thamnolia vermicularis, xue cha.
Torricellia angulata. (intermedia), shui dong gua.
Toddalia asiatica, fei long xhang xue.
Torreya grandis, fei zi. Thesium chinense, bai rui cao.
Trachelospermum jasminoides. luo shi teng.
Tremella fuciformis, yin er.
Tribulus terrestris. bai ji li.
T chosanthes kiriiowii, tian hua fen, gua lou, gua lou pi. Trionyx sinensis, bie jia.
Trogopterus xanthipes, wu ling zhi.
Tussilago farfara. kuan dong hua.
Typha angustata, (latifolia). pu huang.
Typhonium giganteum, bai fu zi. Uncaria rhynchophylla, gou teng.
Usnea diffracta, lao jun xu.
Vaccaria segetaiis, wang bu liu xing.
Valeriana jatamansi, zhi zhu xiang.
Veronica peregrina, xian tao cao. Verbena officinalis, ma bian cao.
Veratrum nigrum, li lu.
Vespertilio superana, ye ming sha.
Vermiculite, jin jing shi.
Viola yedoensis, zi hua di ding. Viscum album, (coloratum), hu ji sheng.
Vitex negundo, (cannabifolia), mu jing. Vitex trifolia, (simplicifolia), man jing zi. Viadimiris souliei, chuan mu xiang. Wikstroemia indica, liao ge wang.
Woodwardia japonica, (unigemmata) gou ji guan zhong'Xanthium sibiricum, cang er g er cao.
Zanthoxylum bungeanum, hua jiao, jiao mu.
Zanthoxylum nitidum, liang mian zhen.
Zanthoxylum planispinum, zhu ye jiao.
Zaocys dhumnades, wu shao she.
Zingiber officinale, sheng jiang, gan jiang.
Zizyphus jujuba, da zao.
Zizyphus spinosa, suan zao ren.
Other bioactive substances that may be used include:
Abscess Root Polemonium reptaπs
Adonis Adonis vernalis
Adrue Cyperus articulatus
Aga Amanita muscaria
Agrimony Agrimonia eupatoria
Alfafa Medicago sativa
Alisma Alisma plantago-aquatica
Alkanet Alkanna tinctoria
Aloe Aloes species
Alpine Cranberry Vaccinium vitis-idaea
Amaranth Amaranthus species
Amargo Quassia amara
American Ivy Parthenocissus quinquefolia
American White Pond Lily Nymphaea odorata
Angelica Angelica archangelica
Anise Pimpinella anisum
Apple Tree Malus domestica
Areca Nut Areca catechu Artichoke Cynara scolymus
Ash Fraxinus excelsior
Asparagus Asparagus officinalis
Balmony Chelone glabra
Bamboo Arundinaria japonica
Barberry Berberis vulgaris
Barley Hordeum species
Basil Ocimum basilicum
Bean Pod Phaseolus vulgaris
Beet Beta vulgaris
Belladonna Atropa belladonna
Bennet's Root Geum urbanum
Betel Nut Piper betle
Beth Root Trillium erectum
Bilberry Vaccinium myrtillus
Birch Betula species
Birthwort Aristolochia clematitis
Bishop's Weed Ammi visnaga
Bistort Persicaria bistorta
Bitter Apple Citrullus colocynthis
Bitter Orange Citrus aurantium
Bittersweet Nightshade Solanum dulcamara
Black Alder Alπus glutinosa
Black Bryony Tamus communis
Black Cohosh Cimicifuga racemosa
Black Currant Ribes nigrum
Black Haw Viburnum prunifolium
Black Hellebore Helleborus πiger
Black Horehound Ballota nigra
Black Mustard Brassica nigra
Black Nightshade Solanum nigrum Black Pepper Piper nigrum
Blackberry Rubus fruticosus
Bladderwort Utricularia vulgaris
Blessed Thistle Cnicus benedictus
Bog Bean Menyanthes trifoliata
Bog Bilberry Vaccinium uliginosum
Boldo Peumus boldus
Boneset Eupatorim perfoiiatum
Borage Borago officinalis
Boxwood Buxu sempervirens
Brooklime Veronica beccabunga
Buckthorn Rhamnus catharticus
Buckwheat Fagopyrum esculentum
Bugle Ajuga reptans
Bugleweed Lycopus virrginicus
Burdock Arctium lappa
Burning Bush Dictamnus albus
Burr Marigold Bidens tripartita
Butcher's Broom Ruscus aculeatus
Cabbage Brassoca oleracea
Cajuput Melaieuca leucadendra
Calamus Acorus calamus
California Poppy Eschscholtzia californica
Camphor Tree Cinnamomum camphora
Canadian Fleabane Erigeron canadensis
Caraway Carum carvi
Cardamom Elettaria cardamomum
Carob Ceratoπia siliqua
Cascara Sagrada Rhamnus purshiana
Cashew Anacardium occidentale
Castor Oil Plant Ricinus communis Catnip Nepeta cataria
Cat's Foot Antennaria dioica
Cayenne Capsicum annum
Celandine Chelidonium majus
Celery Apium graveolens
Centaury Ceπtaurium erythraea
Chaste Tree Vitex agnus-castus
Cherry Laurel Prunus laurocerasus
Chicory Cichorium intybus
Chinese Rhubarb Rheum palmatum
Chive Allium schoenoprasum
Cinnamon Cinnamomum verum
Cinquefoil Potentilla erecta
Clematis Clematis erecta
Clove Syzygium aromaticum
Cocoa Theobroma cacao
Coconut Palm Cocos nucifera
Coffee Coffea arabica
Colchicum Colchicum autumnale
Colt's Foot Tussilago farfara
Columbine Aquilegia vulgaris
Comfrey Symphytum officinale
Common Kidney Vetch Anthyllis vulneraria
Coolwort Tiarella cordifolia
Coriander Coriandrum sativum
Cornflower Centaurea cyanus
Cumin Cuminum cyminum
Cup Plant Silphium perfoiiatum
Curcuma Curcuma xanthorrhizia
Cypress Cupressus sempervirens
Cypress Spurge Euphorbia cyparissias Dandelion Taraxacum officinale
Date Palm Phoenix dactyiifera
Digitalis Digitalis purpurea
Dill Anethum graveolens
Dodder Cuscuta epithymum
Dog Rose Rosa canina
Dogwood Cornus florida
Duckweed Lemna minor
Dyer's Broom Genista tinctoria
Echinacea Purpurea Echinacea purpurea
Elecampane Inula helenium
Elm Bark Ulmus minor
English Chamomile Chamaemelum nobile
English Hawthorn Crataegus laevigata
English Horsemint Mentha longifolia
English Ivy Hedera helix
English Lavender Lavandula angustifolia
English Plantain Plantago lancelolata
Eryngo Eryngium campestre
Eucalyptus Eucalyptus globuius
European Elder Sambucus nigra
European Five-Finger Grass Potentilla reptans
European Golden Rod Solidago virgaurea
European Mistletoe Viscum album
European Peony Paeonia officinalis
European Water Hemlock Cicuta virosa
Evening Primrose Oeπothera biennis
Fennel Foeπiculum vulgare
Fenugreek Trigonella foenum-graecum
Feverfew Tanacetum parthenium
Field Scabious Knautia arvensis Figs Ficus carica
Figwort Scrophularia nodosa
Flax Linum usitatissimum
Fool's Parsley Aethusa cynapium
Forget-Me-Not Myosotis arvensis
Frangula Rhamnus frangula
French Tarragon Artemisia dracunculus
Fringetree Chionanthus virginicus
Frostwort Helianthemum canadense
Fumitory Fumaria officinalis
Gamboge Garcinia hanburyi
Garden Cress Lapidum sativum
Garlic Allium sativum
German Chamomile Marticaria recutita
Germander Teucrium chamaedrys
Ginger Zingiber officinale
Ginkgo Ginkgo biloba
Globe Flower Trollius europaeus
Goat's Rue Galega officinalis
Golden Shower Tree Cassia fistula
Goldenseal Hydrastis canadensis
Gotu Kola Centella asiatica
Goutweed Aegopodium podagraπa
Grains of Paradise Aframomum melegueta
Grape Vitis vinifera
Great Burπet Sanguisorba officinalis
Greater Bindweed Calystegia sepium
Green Tea Camellia sinensis
Ground Pine Ajuga chamaepitys
Heather Calluna vulgaris
Hedge-Hyssop Gratiola officinalis Hemlock Conium maculatum
Hemp Agrimony Eupatorim canπabinum
Hempnettle Galeopsis segetum
Henbane Hyoscyamus niger
Henna Lawsonia inermis
Herb Paris Paris quadrifolia
Herb Robert Geranium robertianum
Hibiscus Hibiscus sabdariffa
High Mallow Malva sylvestris
Hogweed Heracleum sphondylium
Holly Ilex aquifolium
Hollyhock Alcea rosea
Hops Humulus lupulus
Horehound Marrubium vulgare
Horse Chestnut Aesculus hippocastanum
Horseradish Armoracia rusticana
Horsetail Equisetum arvense
Houseleek Sempervivum tectorum
Hydrangea Hydrangea arborescens
Hyssop Hyssopus officinalis
Jaborandi Pilocarpus microphyllus
Jacob's Ladder Polemonium caeruleum
Jalap Ipomoea purga
Jasmine Jasminum officinale
Jimson Weed Datura stramonium
Jojoba Simmondsia chinesis
Juniper Juniperus communis
Kava Kava Piper methysticum
Knotweed Polygonum aviculare
Lady Fern Athyrium filix-femina
Lady's Bedstraw Galium verum Lady's Mantle Alchemilla vulgaris
Larch Larix decidua
Larkspur Delphinium consoiida
Laurel Laurus nobilis
Lavender Cotton Santolina chamaecyparissias
Lemon Balm Melissa officinalis
Lemongrass Cymbopogon citratus
Levant Cotton Gossypium herbaceum
Licorice Glycyrrhiza glabra
Lily-Of-The-Valley Convallaria majalis
Lime Citrus aurantifolia
Linden Tilia species
Lobelia Lobelia inflata
Loosestrife Lysimachia vulgaris
Lotus Nelumbo nucifera
Lovage Levisiticum officinale
Luffa Luffa aegyptica
Lungwort Pulmonaria officinalis
Madder Rubia tinctorum
Ma-Huang Ephedra sinica
Malabar Nut Justicia adhatoda
Male Fern Dryopteris filix-mas
Mandrake Mandragora officinarum
Manna Fraxinus ornus
Marigold Calendula officinalis
Marijuana Cannabis sativa
Marsh Blazing Star Liatris spicata
Marsh Marigold Caltha palustris
Mastic Tree Pistacia lentiscus
Mate Ilex paraguariensis
Mayapple Podophylium peltatum Meadowsweet Filipendula ulmaria
Mercury Herb Mercurialis annua
Mezereon Daphne mezereum
Milk Thistle Silybum marianum
Moneywort Lysimachia nummularia
Monkshood Aconitum napellus
Motherwort Leonurus cardiaca
Mountain Ash Berry Sorbus aucuparia
Mountain Grape Mahonia aquifolium
Mountain Laurel Kalmia latifolia
Mugwort Artemesia vulgaris
Mullein Verbascum densiflorum
Myrrh Commiphora molmol
Myrtle Myrtus communis
Nasturtium Tropaeolum majus
Neem Aπtelaea azadirachta
Noni Morinda citrifolia
Nutmeg Myristica fragrans
Nux Vomica Strychnos nux vomica
Oak Quercus robur
Oats Avena sativa
Oilseed Rape Brassica napus
Oleander Leaf Nerium oleander
Olive Olea europaea
Onion Allium cepa
Oregano Origanum vulgare
Orris Iris species
Papaya Carica papaya
Parsley Petroselinum crispum
Parsnip Pastinaca sativa
Passion Flower Passiflora incarnata Patchouli Pogostemon cablin
Peppermint Mentha piperita
Petasites Petasites hybridus
Peyote Lophophora williamsii
Pimpinella Pimpinella major
Pinus Bark Tsuga canadensis
Pitcher Plant Sarracenia purpurea
Pleurisy Root Asclepias tuberosa
Poisonous Buttercup Ranunculus sceleratus
Poke Phytolacca americaπa
Pomegranate Punica granatum
Poplar Populus species
Poppyseed Papaver somniferum
Potentilla Potentilla ansesrina
Premorse Scabiosa succisa
Psyllim Seed Plantago afra
Pumpkin Cucurbita pepo
Purple Loosestrife Lythrum saiicaria
Quillaja Quillaja saponaria
Quinine Cinchona pubescens
Radish Raphanus sativus
Ragwort Senecio jacobaea
Raspberry Rubus idaeus
Red Clover Trifolium pratense
Red Currant Ribes rubrum
Red Maple Acer rubrum
Red-Spur Valerian Centranthus ruber
Rice Oryza sativa
Rosemary Rosemarinus offcinalis
Rosinweed Silphium laciniatum
Rue Ruta graveolens Rupturewort Hemiaria glabra
Saffron Crocus sativus
Sage Salvia offiiciiinalis
Sarsapariilla Smilax species
Sassafras Sassafras albidum
Savin Tops Juniperus sabina
Saw Palmetto Serenoa repens
Scarlet Pimpernel Anagallis arvensis
Scotch Broom Cytisus scoparius
Scotch Pine Pinus species
Scotch Thistle Onopordum acanthium
Scullcap Scultellaria lateriflora
Scurvy Grass Cochlearia officinalis
Sea Buckthorn Hippophae rhamnoides
Self-Heal Prunella vullgaris
Senna Cassia senna
Shepherd's Purse Capsella bursa-pastoris
Skirret Sium sisarum
Sloe Prunus spinosa
Soapwort Saponaria officinalis
Solomon's Seal Polygonatum multifiorum
Sourhern Bayberry Myrica cerifera
Soybean Glycine soja
Spearmint Mentha spiciata
Speedwell Veronica officinalis
Spikenard Aralia racemosa
Spinach Spinacia oleracea
Spiny Rest Harrow Ononis spinosa
Squill Urgingea maritima
St. John's Wort Hypericum perforatum
Star Anise lllicium verum Stinging Nettle Urtica dioica
Stone Root Collinsonia canadensis
Storax Liquidambar orientalis
Strawberry Fragaria vesca
Sumbul Ferula sumbul
Summer Savory Satureja hortensis
Sunflower Helianthus annus
Swamp Milkweed Asclepias incarnata
Sweet Cicely Myrrhis odorata
Sweet Clover Melilotus officinalis
Sweet Gale Myrica gale
Sweet Marjoram Origanum majorana
Sweet Orange Citrus sinensis
Sweet Vernal Grass Anthoxanthum odoratum
Sweet Violet Viola odorata
Sweet Woodruff Galium odoratum
Tansy Tanacetum vulgare
Taumelloolch Lolium temulentum
Teazle Dipsacus silvestris
Thuja Thuja occidentalis
Thyme Thymus vulgaris
Tobacco Nicotiana tabacum
Tolu Balsam Myroxylon balsamum
Tomato Lycopersicon esculentum
Traveller's Joy Clematis vitalba
Triticum Agropyron repens
Uva-Ursi Arctostaphylos uva-ursi
Valerian Valeriana officinalis
Vervain Verbena officinalis
Wahoo Euoonymus atropurpurea
Wallflower Cheiranthus cheiri Walnut Juglans regia Water Avens Geum rivale Water Fennel Oenanthe aquatica White Bryony Bryonia alba White Hellebore Veratrum album White Mustard Sinapis alba White Nettle Lamium album White Willow Salix species Wild Carrot Daucus carota White Daisy Bellis perennis Wild Indigo Baptisia tinctoria Wild mint Mentha aquatica Wild Radish Raphanus raphanistrum Wild Thyme Thymus serpyllum Wild Yam Dioscorea villosa Willow Herb Epilobium angustifolium Winter Cherry Physalis alkekengi Witch Hazel Hamamelis virginiana Wood Betony Betonica officinalis Wood Sage Teucrium scorodonia Wormseed Oil Chenopodium ambrosioides Wormwood Artemisia absinthium Yarrow Achillea millefolium Yew Taxus baccata Zedoary Curcuma zedoaria
Appropriate combinations of these herbal and/or pharmaceutical formulations in a nanodose preparation may be used therapeutically to treat allergic disorders, cardiovascular system disorders, central nervous system disorders, dermatological conditions, ear disorders, endocrine system disorders, eye disorders, gastrointestinal tract disorders, immune system -disorders, infections, musculoskeletal disorders, neoplasms, obstetric/gynecological disorders, pain and pyrexia, drug dependence, respiratory tract disorders, surgical post-operative conditions, and urogenital system disorders.
While the invention has been herein shown and described in what is presently conceived to be the most practical and preferred embodiment thereof it will be apparent to those of ordinary skill in the art that many modifications may be made thereof within the scope of the invention, which scope is to be accorded the broadest interpretation of the appended claims so as to encompass all equivalent products and procedures.

Claims

WHAT IS CLAIMED IS:
1. An ingestible delivery vehicle containing only about 8 micrograms-0.5 picograms, or about 5-10 microliters of about 6.7 x 10'8 to 2.5 x 10"15 molar solution, of at least one bioactive substance.
2. An ingestible delivery vehicle as recited in claim 1 wherein the at least one bioactive substance is selected from the group consisting essentially of Chinese medicine herbal substances, mother of pearl, stimulants, and the other materials listed in the specification.
3. An ingestible delivery vehicle as recited in claim 1 wherein the delivery vehicle is selected from the group consisting essentially of carbohydrate-based wafers, non- carbohydrate-based wafers, lozenges including lactose pellets, and capsules.
4. An ingestible delivery vehicle as recited in claim 1 wherein the at least one bioactive substance is sprayed onto the delivery vehicle.
5. An ingestible delivery vehicle as recited in claim 1 wherein the delivery vehicle contains only one bioactive substance.
6. An ingestible delivery vehicle as recited in claim 1 wherein the at least one bioactive substance comprises a plurality of bioactive substances collectively present in the amount of only about 8 micrograms - 0.5 picograms.
7. An ingestible delivery vehicle as recited in claim 1 wherein the total amount of bioactive substance is between about 1 x 10"9 to 1 x 10"11 grams.
8. An ingestible delivery vehicle as recited in claim 1 wherein the at least one bioactive substance comprises a formulation comprising Acanthopenax Root Bark, Schizandria Chinensis, Concha Margarita, and Pericarpium Citrus Reticulata.
9. A method of treating a human or animal by neurostimulating the human's or animal's brain to effect a positive physical manifestation by substantially solely influencing the human's or animal's gustatory, or gustatory and olfactory, receptors.
10. A method as recited in claim 9 practiced so as to influence substantially only the gustatory receptors.
1 1. A method as recited in claim 10 practiced by bringing the gustatory receptors into contact with only between about 8 micrograms and 0.5 picograms, or about 5-10 microliters of about 6.7 x 10"8 to 2.5 x 10"15 molar solution, of a bioactive substance.
12. A method as recited in claim 9 practiced by bringing the receptors into contact with only between about 8 micrograms and 0.5 picograms, or about 5-10 microliters of about 6.7 x 10"8 to 2.5 x 10"15 molar solution, of a bioactive substance.
13. A method as recited in claim 9 practiced by bringing the receptors into contact with a plurality of bioactive substances collectively in an amount of only between about 8 micrograms and 0.5 picograms.
14. A method as recited in claim 14 practiced by bringing the receptors into contact with a plurality of bioactive substances collectively in an amount of only between about 1 x 10"9 to 1 x 10'11 grams.
15. A method as recited in claim 9 practiced by the human or animal bringing a delivery vehicle containing an effective amount of at least one bioactive substance into contact with the gustatory receptors.
16. A method as recited in claim 15 practiced so that the positive effectiveness of treatment is substantially the same as if the human or animal was treated with a normal dose of the at least one bioactive substance delivered through the bloodstream.
17. A method as recited in claim 15 practiced to cure or relieve the symptoms of a disease, illness, or condition; and further comprising also treating the human or animal with a normal dose of a bioactive substance delivered through the bloodstream to cure or relieve the symptoms of the same disease, illness, or condition.
18. A method as recited in claim 9 practiced to cure or relieve the symptoms of a disease, illness, or condition conventionally treatable by delivering a bioactive substance to the human or animal through the bloodstream; and further practiced with at least substantially the same effectiveness as the conventional treatment.
19. A method as recited in claim 18 practiced so as to cure or relieve the symptoms of one or more of ADHD, ADD, nervousness, hot flashes, insomnia, bone density loss, anxiety, and drug addiction.
20. A method of treating a human or animal with a disease, illness, or condition, to cure or relieve the symptoms thereof, by bringing into contact with the human's or animal's gustatory receptors at least one bioactive substance in the amount of only between about 8 x 10"6 to 5 x 10"13 grams, or about 5-10 microliters of about 6.7 x 10'8 to 2.5 x 10"15 molar solution.
21. Methods and products as shown and described.
PCT/US2000/025882 1999-09-24 2000-09-21 Delivery of small doses of ingestible treatments WO2001022934A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU77068/00A AU7706800A (en) 1999-09-24 2000-09-21 Delivery of small doses of ingestible treatments

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15558699P 1999-09-24 1999-09-24
US60/155,586 1999-09-24
US66246800A 2000-09-15 2000-09-15
US09/662,468 2000-09-15

Publications (2)

Publication Number Publication Date
WO2001022934A2 true WO2001022934A2 (en) 2001-04-05
WO2001022934A3 WO2001022934A3 (en) 2001-08-16

Family

ID=26852432

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/025882 WO2001022934A2 (en) 1999-09-24 2000-09-21 Delivery of small doses of ingestible treatments

Country Status (2)

Country Link
AU (1) AU7706800A (en)
WO (1) WO2001022934A2 (en)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10354667A1 (en) * 2003-11-22 2005-07-14 Phytovisions Gmbh & Co. Kg Composition containing extracts of Lycium and Schisandra, useful in cosmetics, foods and supplements, have antistress and anti-ageing activities, lack potentially harmful lignans and schisandrins
US7001622B1 (en) 2003-06-30 2006-02-21 Robert Berndt Composition and method for treatment and prevention of pruritis
US7867524B2 (en) 2007-10-05 2011-01-11 David Rowland Energizing formulation
US8067045B2 (en) 2005-03-03 2011-11-29 Pharmanex, Llc Nutritional formulations and associated methods
CN102716346A (en) * 2012-06-28 2012-10-10 任兆禄 Detoxification and drug-relief medicine
WO2013192114A1 (en) * 2012-06-22 2013-12-27 Golden Biotechnology Corporation Methods and compositions for treating arteriosclerotic vascular diseases
WO2014008351A3 (en) * 2012-07-06 2014-02-27 Omeros Corporation Andrographis paniculata compositions and methods for treatment of addictions
WO2014081715A1 (en) * 2012-11-20 2014-05-30 Vita Naturale, Llc Compositions and methods for their dermatological use
WO2015171977A1 (en) 2014-05-08 2015-11-12 Access Business Group International Llc Method for improving memory of a subject using a composition comprising cistanche and ginkgo extracts
CN107890476A (en) * 2016-10-04 2018-04-10 康贝株式会社 For the composition for the expression change for making clock gene
CN108813608A (en) * 2018-05-25 2018-11-16 陕西黄龙国寿堂生物工程有限公司 A kind of production method of sea-buckthorn wilsonii cream
WO2019027244A3 (en) * 2017-08-03 2019-03-28 주식회사 일원바이오 Composition for improving prevention and treatment of fatty liver containing amomum vilosum extract.
WO2019077407A1 (en) * 2017-10-19 2019-04-25 Yale University Inhibition of androgen receptor by extracts of medicinal herbs and compositions thereof
WO2020022923A1 (en) * 2018-07-24 2020-01-30 "Bio 8", Limited Liability Company Plant extract-based biologically active supplement having antibacterial, antiviral and antifungal action
CN110907574A (en) * 2019-11-06 2020-03-24 桂林三金药业股份有限公司 Quality control method, quality control spectrogram and construction method of traditional Chinese medicine composition
CN110999860A (en) * 2019-12-17 2020-04-14 田继兰 Method for researching insomnia resistance action mechanism of Sugelia based on amino acid metabonomics
WO2020246976A1 (en) * 2019-06-06 2020-12-10 Muhammed Majeed Composition for prostaglandin transporter inhibition and related therapeutic applications
US20210401906A1 (en) * 2020-06-30 2021-12-30 Glac Biotech Co., Ltd. Composition for promoting defecation and uses thereof
CN114747697A (en) * 2022-04-20 2022-07-15 汕头大学 Soft granular compound feed for scylla paramamosain with long shelf life and preparation method thereof
CN115054589A (en) * 2022-05-31 2022-09-16 海南海药本草生物科技有限公司 Oral instant film agent containing levo-borneol and preparation method thereof
CN115154521A (en) * 2022-08-23 2022-10-11 刘爱民 Composition and preparation for treating psoriasis caused by external cold and internal heat and preparation method
CN115177690A (en) * 2022-07-07 2022-10-14 张振录 Traditional Chinese medicine composition for treating osteoarthritis and preparation method thereof
CN115177657A (en) * 2022-08-15 2022-10-14 正大青春宝药业有限公司 Application of selfheal in improving safety of medicine containing radix stephaniae tetrandrae
CN115364154A (en) * 2022-10-18 2022-11-22 江西中医药大学 Preparation method of traditional Chinese medicine composition, traditional Chinese medicine tea and traditional Chinese medicine tea bag
CN115501273A (en) * 2021-06-23 2022-12-23 广西大学 Application of traditional Chinese medicine compound effective extract in preparation of medicine for resisting eimeria tenella
US20230119836A1 (en) * 2021-10-18 2023-04-20 Infinitus (China) Company Ltd. Chinese herbal medicine composition for relieving hearing loss and preparation method and use thereof
US20230165926A1 (en) * 2021-12-01 2023-06-01 Meyer Health Jiangsu Co., Ltd. Antidepressant food and method for preparing the same
CN116327830A (en) * 2023-05-04 2023-06-27 海南医学院 Traditional Chinese medicine composition for resisting oxidization and regulating intestinal flora and preparation method thereof
US11969447B2 (en) * 2020-06-30 2024-04-30 Glac Biotech Co., Ltd. Use of spray-dried powder derived from lactic acid bacterial strains and herbal extracts for promoting defecation

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115581718B (en) * 2022-11-24 2023-03-14 四川省畜牧科学研究院 Phyllanthus emblica and groundsel composition and antifungal application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0567352A1 (en) * 1992-04-24 1993-10-27 Wisconsin Alumni Research Foundation Use of 1-alpha,24(R)-dihydroxy-22(E)-dehydro-vitamin D3 for the manufacture of a medicament for the treatment of osteoporosis
US5431881A (en) * 1993-12-10 1995-07-11 Palacios; Henry J. Treatment of hair loss and dermatological problems
US5837254A (en) * 1996-11-14 1998-11-17 Chen; Yu Method of treating candida and cryptococcus fungal infections by administering gentian
WO2000054794A1 (en) * 1999-03-18 2000-09-21 Yng Wong Quing Non Wafer delivery system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0567352A1 (en) * 1992-04-24 1993-10-27 Wisconsin Alumni Research Foundation Use of 1-alpha,24(R)-dihydroxy-22(E)-dehydro-vitamin D3 for the manufacture of a medicament for the treatment of osteoporosis
US5431881A (en) * 1993-12-10 1995-07-11 Palacios; Henry J. Treatment of hair loss and dermatological problems
US5837254A (en) * 1996-11-14 1998-11-17 Chen; Yu Method of treating candida and cryptococcus fungal infections by administering gentian
WO2000054794A1 (en) * 1999-03-18 2000-09-21 Yng Wong Quing Non Wafer delivery system

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHAVEZ M L ET AL: "HOMEOPATHY" HOSPITAL PHARMACY,LIPPINCOTT, PHILADELPHIA,US, vol. 33, no. 1, 1998, pages 41-50, XP000925059 ISSN: 0018-5787 *
NEGTIEN G; TRAISNEL M; VERAIN A: "MEDICAMENTS HOMEOPATIQUES" 1986 , GALENICA, FR, PARIS, TECHNIQUE ET DOCUMENTATION XP002162252 page 77, line 31 -page 78, line 15 page 87, line 33 -page 88, line 4 page 97, line 21 - line 42 *

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7001622B1 (en) 2003-06-30 2006-02-21 Robert Berndt Composition and method for treatment and prevention of pruritis
DE10354667A1 (en) * 2003-11-22 2005-07-14 Phytovisions Gmbh & Co. Kg Composition containing extracts of Lycium and Schisandra, useful in cosmetics, foods and supplements, have antistress and anti-ageing activities, lack potentially harmful lignans and schisandrins
US8067045B2 (en) 2005-03-03 2011-11-29 Pharmanex, Llc Nutritional formulations and associated methods
US7867524B2 (en) 2007-10-05 2011-01-11 David Rowland Energizing formulation
WO2013192114A1 (en) * 2012-06-22 2013-12-27 Golden Biotechnology Corporation Methods and compositions for treating arteriosclerotic vascular diseases
CN102716346A (en) * 2012-06-28 2012-10-10 任兆禄 Detoxification and drug-relief medicine
WO2014008351A3 (en) * 2012-07-06 2014-02-27 Omeros Corporation Andrographis paniculata compositions and methods for treatment of addictions
WO2014081715A1 (en) * 2012-11-20 2014-05-30 Vita Naturale, Llc Compositions and methods for their dermatological use
WO2015171977A1 (en) 2014-05-08 2015-11-12 Access Business Group International Llc Method for improving memory of a subject using a composition comprising cistanche and ginkgo extracts
CN107890476A (en) * 2016-10-04 2018-04-10 康贝株式会社 For the composition for the expression change for making clock gene
WO2019027244A3 (en) * 2017-08-03 2019-03-28 주식회사 일원바이오 Composition for improving prevention and treatment of fatty liver containing amomum vilosum extract.
JP7303558B2 (en) 2017-10-19 2023-07-05 イェール ユニバーシティー Inhibition of androgen receptors by herbal extracts and compositions of said extracts
WO2019077407A1 (en) * 2017-10-19 2019-04-25 Yale University Inhibition of androgen receptor by extracts of medicinal herbs and compositions thereof
US11839639B2 (en) 2017-10-19 2023-12-12 Yale University Inhibition of androgen receptor by extracts of medicinal herbs and compositions thereof
CN111372597A (en) * 2017-10-19 2020-07-03 耶鲁大学 Androgen receptor inhibition by medicinal herb extracts and compositions thereof
JP2021500023A (en) * 2017-10-19 2021-01-07 イェール ユニバーシティーYale University Inhibition of androgen receptors by herbal extracts and the composition of the extracts
CN108813608A (en) * 2018-05-25 2018-11-16 陕西黄龙国寿堂生物工程有限公司 A kind of production method of sea-buckthorn wilsonii cream
WO2020022923A1 (en) * 2018-07-24 2020-01-30 "Bio 8", Limited Liability Company Plant extract-based biologically active supplement having antibacterial, antiviral and antifungal action
WO2020246976A1 (en) * 2019-06-06 2020-12-10 Muhammed Majeed Composition for prostaglandin transporter inhibition and related therapeutic applications
CN114126420A (en) * 2019-06-06 2022-03-01 萨米-萨宾莎集团有限公司 Compositions for prostaglandin transporter inhibition and related therapeutic applications
CN110907574A (en) * 2019-11-06 2020-03-24 桂林三金药业股份有限公司 Quality control method, quality control spectrogram and construction method of traditional Chinese medicine composition
CN110999860A (en) * 2019-12-17 2020-04-14 田继兰 Method for researching insomnia resistance action mechanism of Sugelia based on amino acid metabonomics
CN110999860B (en) * 2019-12-17 2021-12-17 田继兰 Method for researching insomnia resistance action mechanism of Sugelia based on amino acid metabonomics
US20210401906A1 (en) * 2020-06-30 2021-12-30 Glac Biotech Co., Ltd. Composition for promoting defecation and uses thereof
US11969447B2 (en) * 2020-06-30 2024-04-30 Glac Biotech Co., Ltd. Use of spray-dried powder derived from lactic acid bacterial strains and herbal extracts for promoting defecation
CN115501273A (en) * 2021-06-23 2022-12-23 广西大学 Application of traditional Chinese medicine compound effective extract in preparation of medicine for resisting eimeria tenella
US20230119836A1 (en) * 2021-10-18 2023-04-20 Infinitus (China) Company Ltd. Chinese herbal medicine composition for relieving hearing loss and preparation method and use thereof
US20230165926A1 (en) * 2021-12-01 2023-06-01 Meyer Health Jiangsu Co., Ltd. Antidepressant food and method for preparing the same
CN114747697B (en) * 2022-04-20 2023-09-26 汕头大学 Scylla paramamosain soft pellet compound feed with long shelf life and preparation method thereof
CN114747697A (en) * 2022-04-20 2022-07-15 汕头大学 Soft granular compound feed for scylla paramamosain with long shelf life and preparation method thereof
CN115054589A (en) * 2022-05-31 2022-09-16 海南海药本草生物科技有限公司 Oral instant film agent containing levo-borneol and preparation method thereof
CN115054589B (en) * 2022-05-31 2023-10-24 海南海药本草生物科技有限公司 Oral instant film agent containing L-borneol and preparation method thereof
CN115177690B (en) * 2022-07-07 2023-09-19 张振录 Traditional Chinese medicine composition for treating osteoarthritis and preparation method thereof
CN115177690A (en) * 2022-07-07 2022-10-14 张振录 Traditional Chinese medicine composition for treating osteoarthritis and preparation method thereof
CN115177657A (en) * 2022-08-15 2022-10-14 正大青春宝药业有限公司 Application of selfheal in improving safety of medicine containing radix stephaniae tetrandrae
CN115177657B (en) * 2022-08-15 2023-08-04 正大青春宝药业有限公司 Application of selfheal in improving safety of stephania tetrandra-containing medicament
CN115154521B (en) * 2022-08-23 2023-07-25 刘爱民 Composition and preparation for treating psoriasis caused by external cold and internal heat and preparation method
CN115154521A (en) * 2022-08-23 2022-10-11 刘爱民 Composition and preparation for treating psoriasis caused by external cold and internal heat and preparation method
CN115364154A (en) * 2022-10-18 2022-11-22 江西中医药大学 Preparation method of traditional Chinese medicine composition, traditional Chinese medicine tea and traditional Chinese medicine tea bag
CN116327830A (en) * 2023-05-04 2023-06-27 海南医学院 Traditional Chinese medicine composition for resisting oxidization and regulating intestinal flora and preparation method thereof
CN116327830B (en) * 2023-05-04 2024-04-12 海南医学院 Traditional Chinese medicine composition for resisting oxidization and regulating intestinal flora and preparation method thereof

Also Published As

Publication number Publication date
WO2001022934A3 (en) 2001-08-16
AU7706800A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
WO2001022934A2 (en) Delivery of small doses of ingestible treatments
US20220031781A1 (en) Cannabis oil extracts and compositions
US20180344661A1 (en) Cannabis oil compositions and methods for preparation thereof
CN101524524B (en) Drug for treating severe cold and preparation method thereof
CN102018937B (en) Medicament for treating acne and preparation method thereof
CN100353973C (en) Medicinal tea for treating rhinopathia
US11596618B2 (en) Oral cannabinoid delivery formulations with mouthfeel experience enhancers
US20220331344A1 (en) Oral formulations of psychotropic macrofungus botanical extracts with mouthfeel experience enhancers
CN106214668B (en) Propofol flexible nano-liposomes patch and its application
CN101352546B (en) Chinese medicine for treating lung cyst, pulmonary fibrosis and suppressing cough and preparation method thereof
CN107456491A (en) A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof
NZ228593A (en) Process for the preparation of magnetically influenced homeopathic formulations
CN111358906B (en) Traditional Chinese medicine composition suitable for exogenous diseases
CN114533777A (en) Aromatic traditional Chinese medicine essential oil slow-release material and preparation method and application thereof
CN101623474B (en) Preparation method of Shengui antler oral solid preparation
CN104491806A (en) External traditional Chinese medicine for treating allergic rhinitis
CN101147767B (en) Preparation method of medicinal composition for treating acne
US20210212929A1 (en) Oral formulations for mitigating acute cannabis intoxication
CN102100816A (en) Chinese herb preparation for treating cold type common cold
CN101991697A (en) Preparation with functions of clearing away heat and reducing fire and preparation method thereof
US20210213083A1 (en) Water soluble cannabinoid powders
CN108030823A (en) A kind of Chinese medicine for treating rhinitis
CN1449800A (en) Traditional Chinese medicine for treating wind-cold type of common cold and preparation process thereof
Tripathi Traditional knowledge digital library: The challenges ahead
CN101874877A (en) Medicine combination for promoting blood circulation and removing blood stasis and preparation method thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP